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Title of Thesis .THE _ INV^I^TION _ OF _ l^ABOLIC BOTE _ DISEASE BY IN VIVO NEUTRON
.ACTIVATION..ANALYSIS...
A technique for measuring total body calcium (TBCa) by in vivo
neutron activation analysis (IVNAA) was described. It had a
precision of 1.8% for a dose of 13 mSv. TBCa was measured in 40
healthy volunteers and the mean value (SD) for 20 men was 1143g
(134g) and for 20 wcmen it was 821 g (124g).
A formula for predicting TBCa (TBCap) from height in men and
from span and years postmenopause in wcmen was derived. The results
from patient groups were expressed as a ratio of TBCa to TBCap, the
calcium ratio (CaR).
The mean CaR in eight wcmen with wrist fracture was 1.00
(0.10, SD) and in 14 wcmen with vertebral fractures was 0.87 (0.06,
SD). The latter group had a significantly lower CaR than the female
controls of 1 .00 (0.07, SD, P<0.001). The TBCa was normalized for
span alone to obtain an index reflecting the bone lost since the
menopause, the osteopaenia index. Patients with vertebral fractures
all had values below 0.78 and so this was considered the fracture
threshold.
A low mean value for CaR was found in 14 patients with primary
hyperparathyroidism. Significant increases in TBCa were found in
four out of seven patients followed for up to 34 months
postoperatively. The initial mean CaR was 0.85 (P<0.001 ).
Seven wcmen with osteomalacia due to malabsorption had a low
mean TBCa and osteopaenia index (P<0.001). One patient who was
remeasured after eight months of vitamin D therapy had an 18%
increase in TBCa, the largest increase found in any patient in the
present study.
Twelve patients were measured prior to, or shortly after,
renal transplantation. The eight men had a mean CaR of 0.93
(P<0.05) and the four wcmen a mean value of 0.82. There was no
significant change following renal transplantation over an average
of 17 months. This result was attributed to a balance between the
healing of renal osteodystrophy and the osteopaenic effect of
steroid therapy.
Forty-one men studied after peptic ulcer surgery had a low
mean CaR of 0.94 (0.07, SD, P<0.01 ). The reduction in bone mass was
similar for patients after partial gastrectomy and for those after
vagotomy and drainage procedures. The hypothesis was proposed that
bone disease after peptic ulcer surgery was due to secondary
hyperparathyroidism caused by calcium malabsorption and not by
subclinical osteomalacia. This was supported by the following
findings. Plasma 25-hydroxycalciferol was normal when compared
with season-matched controls. However, there were low plasma
calcium and high parathyroid hormone levels compared with
age-matched controls. Dietary calcium was normal but 7-day calcium
retention was increased when the calcium was given as a solution.
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CHAPTER 1. PRODUCTION.
Total body calcium measurements were first
described in 1968 (Chamberlain et al., 1968, and Palmer et al.,
1968). Five other groups have since reported their methods (Table
1a).
The two groups from the United States (Nelp et al., 1972, and
Cohn et al., 1976a) have reported their results as absolute values
and this allows comparison between healthy volunteers and patient
groups. The present study was planned to test their findings and
extent their studies, some of which were based on small numbers of
patients (Table 1b). Recently the groups based at the Hammersmith
Hospital in London and in Leeds have started reporting their
results in absolute values (Hesp et al., 1982, Horsman et al.,
1983).
All the types of metabolic bone disease shown in Table 1b were
investigated in the present study. In addition, groups of patients
with osteomalacia, wrist fractures, and patients who have had renal
transplantation and peptic ulcer surgery involving operations other
than partial gastrectomy were studied.
In the previous studies of TBCa there has been a tendency to
describe abnormalities in bone mass in different groups but not to
relate these to other measurements such as biochemical changes.
Such relationships will be persued in the present study.
The methods used in this study are described in Chapter 2. The
reference ranges for TBCa, biochemical measurements, dietary
intakes, and body measurements are established in Chapter 3. Here a
formula is described for predicting TBCa from age and body size. In
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Table Jb. sectional studies of TBCa in patients with
metabolic bone disease.





Osteoporosis 44 Aloia et al.(1978)
26 Chesnut et al.(1977)







Hyperparathyroidism 8 (pre-operative) Cohn et al.(1973)
Partial gastrectany 18 Zanzi et al.(1977)
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keeping with the convention adopted by Cohn et al.(1974) the ratio
of TBCa to predicted TBCa is termed the calcium r^tio (Ca^).
The TBCa of wanen with spontaneous vertebral fractures is
described in Chapter 4 and Ca^ is calculated to determine whether
the reduction in bone mass is simply due to age and body size. An
attempt is made to determine a fracture threshold by normalizing
the TBCa for body size alone. Similarly, wanen with wrist fracture
are studied.
The results of TBCa are also described in Chapters 5 and 6 for
wanen with primary hyperparathyroidism and wanen with osteomalacia.
The concept of a fracture threshold is tested on these groups. The
effect of these disturbances in calcium metabolism on bone mass is
assessed by calculating Ca^ and the effect of therapy on bone mass
is described. An attempt is made to relate the biochemical findings
to the changes in bone mass.
The mean TBCa of patients on haemodialysis for end-stage renal
disease is normal according to reports from the United States (Cohn
et al., 1975, Denney et al., 1973). The results of TBCa in Scottish
patients is described and the effect of renal transplantation is
noted. This has not been studied by TBCa measurements before, but
studies using other techniques for measuring bone mass have shown
large falls in bone mass in the first year after transplantation
(Aird and Pierides, 1977, Lindsay et al., 1976). There has been a
recent trend towards using lower doses of steroids to prevent
transplant rejection and this would be expected cause less of a
reduction in bone mass (McGeown et al., 1977). The changes in bone
mass are related to the dramatic biochemical changes after this
operation.
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Finally, this technique is applied to patients after peptic
ulcer surgery in Chapter 8. TBCa has been reported to be low iff
patients after partial gastrectomy (Zanzi et al., 1977). However no
technique has shown a reduction in bone mass in patients following
the newer types of operation for peptic ulcer.
Partial gastrectomy (Figure 1a) was the commonest operation
perfcmed for peptic ulcer between the 1930's and the mid-1960's
(Figure 1d). Many patients have undergone this procedure and its
effects on calcium metabolism have been reported extensively. The
effects on calcium metabolism of the newer operations that were
introduced have not been studied in such detail. The operations of
vagotomy and drainage with either a pyloroplasty or a
gastroenterostomy (Figure 1b) became popular in the mid-1960's
(Figure 1e) until highly-selective vagotomy (Figures 1c and 1f) was
introduced as it was considered to give rise to fewer
complications. These trends in popularity of operation technique
were described recently in a British Medical Journal leading
article (1981).
The different effects of each of these operations on the
anatcmy of the upper gastrointestinal tract permit study of the
effects of duodenal bypass, reduction of acid secretion, vagotomy,
and partial gastrectomy by combining the patients in different
combinations. For example, the effect of duodenal bypass can be
studied by combining the results of patients with Polya partial
gastrectomy (with and without vagotomy) with gastroenterostomy
(with and without vagotomy) and comparing them with the results
from those with Billroth I partial gastrectomy, vagotomy and
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Figure 1a. Partial gastrectomy for peptic ulcer.
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Figure 1c. gastroenterostomy and highly-selective vagotomy for
peptic ulcer.
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OPERATIONS FOR PEPTIC ULCER AT THE WESTERN GENERAL
HOSPITAL, EDINBURGH : GASTRECTOMY
YEAR
Figure 1d. Annual rate of partial gastrectomy operations.
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OPERATIONS FOR PEPTIC ULCER AT THE WESTERN GENERAL
HOSPITAL, EDINBURGH : VAGOTOMY AND "DRAINAGE"
YEAR
Figure 1 e. Annual rate of vagotomy and drainage operations.
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OPERATIONS FOR PEPTIC ULCER AT THE WESTERN GENERAL
HOSPITAL, EDINBURGH : GASTROENTEROSTOMY AND HIGHLY-
SELECTIVE VAGOTOMY
* « HIGHLY-SELECTIVE VAGOTOMY
YEAR
Figure 1f. Annual rate of gastroenterostomy and H.S.V. operations.
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CHAPTER 2. METHODS.
A^_ NEUTRON ACTIVATION ANALYSIS.
1. Principle.
The patient is exposed to a beam of partially-moderated fast
48 / 49 49
neutrons. These induce the reaction Ca(n,s) Ca. The Ca decays
with a half-life of 8.8 minutes and emits gamma-rays at 3.1 MeV
which are detected by sodium iodide crystals.
48
Ca makes up 0.186% of elemental calcium and calcium makes up
25.7% of the dry weight of bone (Pelligrino and Blitz, 1965). In
health, 99% of total body calcium is present in bone (Heaney,1963)
and so TBCa is closely related to skeletal mass.
2. Technique for measuring total body calcium (TBCa).
This has been described by Kennedy et al.(1982).
a. Activation.
The neutron beam was produced by the MRC
Cyclotron in Edinburgh (Williams et al.,1979). The mean energy of
the neutrons was 6.5 MeV. The patient stood in a kiosk made fran 3
cm thick polyethelene sheets mounted on a turntable (Figure 2a).
The sheets acted as premoderators to reduce the energy of the
neutrons. A fixed neutron dose was given to the patient in two
successive irradiations each lasting about 22 seconds with the
kiosk rotating through 180 degrees in 18 seconds between the two
irradiations. The patient was positioned 5.4m from the cyclotron
target. The total radiation dose was measured by a
tissue-equivalent ionization chamber and was 1.68 mGy. The total
dose equivalent received was 13.2 mSv (1.7 ran). A sodium carbonate
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standard was activated simultaneously. This was used to correct for
rv variation in the activation procedure.
b. Measurement of induced activity.
The patient was transferred
from the Cyclotron to a whole-body counter with a mean transit time
of six minutes. Four sodium iodide crystals (15 cm in diameter and
10 cm thick) were mounted in the whole-body counter (Figure 2b).
The patient was scanned four times over 2 m, and each scan took
five minutes. The gamma-ray spectrum between 0 and 4 MeV was
recorded on a multi-channel analyser. A 20-minute background count
using a non-activated phantcm was then subtracted frcm the
patient's spectrum and the difference was punched out on paper tape
for spectral analysis.
c. Spectral analysis.
Gamma-ray spectra for calcium, sodium,
chlorine, phosphorus, and potassium were fitted to the patient's
spectrum by the least squares technique (Smith and Tothill,1979).
The amount of calcium calculated in this way was divided by the
count frcm the sodium carbonate standard which had been counted for
20 minutes and an allowance made for radioactive decay. A calcium
value in grams was obtained but allowance had to be made for the
effects of body height, fat thickness, and the gap between the
patient and the wall of the box (see below).
d. Reproducibility.
This was assessed by repeatedly activating
a phantom filled with a solution of a known amount of calcium salt
and by repeatedly activating a skeleton encapsulated in
tissue-equivalent rubber. The reproducibility was expressed as the
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coefficient of variation (CV) and was 1.7% for a calcium content of
10D© g and ' Z11 for a calcium content of 700 g. In a smaller
subject with TBCa of 500 g the CV would rise to 3%.
e. Measurement corrections.
Allowances were made for height as
the neutron flux diminished away from the centre of the beam, for
fat as this attenuates the neutron beam, and for the air gap
between the box and the patient as this also attenuates the beam.
Experiments with fluid-filled phantoms allowed the following
equation to be derived.
TBCa = Measured calcium x height correction x depth correction
x fat correction x wall correction
where,
2
height correction = 0.5 x (height - 1.5) +1
depth correction = 1.6 x (depth - TST - 0.2) + 1
fat correction = 3.6 x ((TST + LST)/2) + 1
wall correction = 1 .0 x (wall separation - depth) + 1
where,
TST was trunk skinfold thickness
LST was limb skinfold thickness
3. Technique for measuring forearm caclium (FCa).
a. Activation.
The bones of the non-dcminant forearm were
activated in an irradiation chamber for 10 minutes as described by
Smith and Tothill (1979) and shown in Figure 2c. The irradiation
dose for four measurements, averaged over the forearm, was 70 mSv
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Figure 2b. Whole body counter.
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b. Measurement of induced activity.
The patient was transferred to the part -foody with
a transit time of one minute. The counter was made of two sodium
iodide crystals which were 15 cm in diameter and 10 cm thick and
were encased in lead (Figure 2d). Counting lasted for 1000 seconds.
c. Spectral analysis.
This was performed as for TBCa.
d. Reproducibility.
This was estimated as 2.1% by repeatedly
activating a cadaver limb. In practice it was 2.6% due to patient
movement.
e. Normalization.
Tothill et al.(1979) attempted to normalize
for body size by dividing the PCa value by the cube of the height.
The resulting CV of the normal range was higher than that for TBCa
and make it less suitable was comparison between groups. In the
present studies FCa was only used for measuring changes in bone
mass. Smith et al.(1981) have shown that both absolute
measurements of FCa and changes in FCa relate closely to results of
photon absorptimetry of the forearm.
7-DAY CALCIUM RETENTION.
The method of Mallette et al.(1975) was used. A background
count was made for 5 minutes in the energy range 1.18 to 1.46 MeV
using the whole-body counter (Figure 2b). After an overnight fast
47the patient was given 37 to 111 kBq (1 to 3 microCi) of Ca in a
calcium chloride solution containing 90 mg calcium. Two hours later








Detectorpushed intocentralshield Forearm support
Crystalface Figure2d.Detectionapparatusf rFCamea urements.
fasted for a further two hours. Seven days later a third
47
measurement was made. It was assumed that by this -"ll the Ca
47
in the faeces had been excreted. A standard solution of Ca was
counted shortly after the patient to allow for radioactive decay.
The reproducibility of the method was reported as 5.4% by Mallette
et al.(1975).
CL BIOCHEMICAL ESTIMATIONS.
Blood was taken in the non-fasting state
and without tourniquet. Samples for parathyroid hormone (PTH)
estimation were put into tubes in melting ice, centrifuged
immediately, and stored at -20° C until the study was completed.
The plasma samples were then assayed in batches with samples frcm
the same patient in the same batch. A similar approach was used for
plasma 25-hydroxycalciferol (25-OHD), although there was less hurry
in centrifuging the sample. The remaining plasma biochemical
analysis was usually performed on the day of sampling.
Twenty-four hour collections of urine were made into bottles
without preservative. Clear instructions were given in writing
about the timing of the collection and advice given on the
avoidance of gelatin-rich food. An aliquot of the sample was frozen
at -20° C.
Plasma 25-OHD was measured using the competitive
protein-binding assay of Preece et al.(1974). This assay uses serum
frcm vitamin D-deficient rats as the binding protein and
dextran-coated charcoal to remove unreacted
26 (27) -^H-25-hydroxycholecalciferol. The assay was preceded by
chromatography. The sensitivity was 12.5 pg and the effective
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sensitivity was 1.3 nmol/1. The intra-assay variation was 8.3% and
iJhe Lw-assay variation was 8 to 16.5%, depending* 'csri
concentration. In this assay 25-080^ was as effective as 25-OHD^ at
displacing labelled 25-OHD^ from rat serum binding protein and 40
times more effective than vitamin D^. Other steroids showed no
significant cross-reaction in this assay (Preece et al., 1974).
Plasma PTH was measured by radioimmunoassay using a
modification of the method of Woo and Singer (1974). The assay used
guinea-pig antiserum to bovine PTH, bovine PTH as the standard, and
radioiodinated bovine PTH as the labelled hormone. The antiserum
was directed mainly against the N-terminal part of the PTH
molecule. The serum and antiserum were incubated at 4° C for 3 days
and then radioiodinated bovine PTH was added and incubation
continued for a further three days at 4° C. The hormone-antiserum
complex was precipitated by the addition of donkey anti-guinea-pig
antiserum (and not by charcoal as used by Woo and Singer, 1974) and
the radioactivity in the bound fraction was counted. The
inter-assay variation was 10 to 12% and the effective sensitivity
was 0.16 to 0.18 mcg/1.
Plasma calcium and urine calcium were measured by atcmic
absorption spectosoopy. The plasma calcium was corrected to an
albumin of 40 g/1 (this was approximately the mean value in the
control group) using the formula recommended by the Lancet leading
article (1979) with a correction factor of 0.02 mmol Ca/g albumin.
Magnesium was also measured by atomic absorption spectroscopy,
inorganic phosphate by a colorimetric method, and alkaline
phosphatase by the method of Kind and King (1 954).
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el sociM, anna
Alcohol consunption was expressed as the number
of units consumed during a typical week. Unit equivalences were
half a pint of beer, a measure of spirits, a glass of sherry, or a
glass of wine (Chick, 1982). Patients were classified as
abstainers, previous drinkers, moderate drinkers (less than 16
units per week - the mean per capita consumption in the United
Kingdom), or heavy drinkers.
Cigarette consumption was expressed as the number of
cigarettes smoked during a typical week. All cigarettes were
considered equivalent. The categories were designed to allow
comparison with the groups of Lee (1976). For pipe and cigar
smokers one ounce of tobacco (28 g) was taken as equivalent to 20
cigarettes.
The tables published by the Office of Population Censuses and
Surveys (1970) were used. Occupation was taken as that persued for
most of the person's life except for a married wcman where it was
taken as that of her husband.
EL BODY MEASUREMENTS.
Height was measured in metres, to the nearest
cm, using a wall-mounted ruler with sliding headpiece. Armspan was
also measured in metres, to the nearest cm, using graph paper
mounted on the wall. Weight was measured in kilograms, to the
nearest 0.1 kg, using an Avery beam balance. Patients wore light
indoor clothing.
Skinfold thickness was measured at four sites, to the nearest
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ran, using Harpenden calipers (British Indicators Ltd, St Albans,
Herts). The biceps site wast '"ve midpoint of the muscle
with the arm hanging vertically. The triceps site was taken as the
point equidistant between the olecranon and acromion processes. The
subscapular site was below the inferior angle of the scapula at 45
degrees to the vertical. The suprailiac site was above the iliac
crest in the midaxillary line. These four skinfold measurements
could be used to predict percent body fat using the tables of
Durnin and Wcmersley (1974).
Lean body mass (LBM) was calculated from body weight (W) and
percent body fat (F) using the following equation:
LBM = W - (W x F/100)
Ideal weight (IW) was predicted from height using the tables
given in the Statistical Bulletin of the Metropolitan Life
Insurance company (no.40, 1959). These tables included an
assessment of body frame. All patients were assumed to be of medium
frame in keeping with the convention adopted by others (eg. Baird
et al., 1974). The percent of body weight above the ideal weight
(%IW) was calculated :
%IW = (W - IW)/W x 100




The standard methods for t-test, chi-square,
Wilooxon rank sum, regression (single and multiple) were performed
as described by Armitage (1971). The analysis of data frcm patients
- 29 -
after peptic ulcer surgery was performed on a mainframe computer
(Digital Equip\. . „ _ tion, DEC-20) using a statistical package
produced by the Pennsylvania State University ("Minitab"). Methods
which were complex or unusual are described in the Appendix.
Levels of significance are designated by asterisks in the
tables. One, two, and three asterisks indicate P<0.05, P<0.01, and
P<0.001 , respectively.
Gj_ CONSEM1.
Informed consent was obtained in writing frcm
all patients. The studies were approved by the hospital ethics
committee and by the Administration of Radioactive Substances
Advisory Committee (ARSAC).
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CHAPTER 3. CONTROL GROUPS FOR TBCa AND SEASONAL VARIATION OF PLASMA
25-OHD.
A. PATIENTS.
1. Controls for TBCa.
Forty volunteers aged 40 to 70 years, 20 men
and 20 women, responded to adverts placed in the hospital
newsletter, the newspaper of a local factory and of the local
police station, and to a published interview with the Edinburgh
Evening News and with BBC Radio Scotland's "Good Morning Scotland".
Other volunteers were excluded from the study as they suffered frcm
disease, or were taking therapy, likely to affect bone mass. Wcmen
with fractures of the wrist, hip, or vertebra were excluded.
The following measurements were made: serum or plasma calcium,
phosphate, magnesium, alkaline phosphatase, albumin, PTH, 25-OHD,
creatinine, and thyroxine; full blood count; 24-hour urinary
excretion of calcium, phosphate, magnesium, hydroxyproline, and
creatinine; weight, height, armspan, body thickness, skinfold
thickness at four sites; and TBCa. These measurements were made
between April 1979 and April 1981 and during all seasons.
2. Controls for plasma 25-OHD.
Twenty-six members of hospital staff
agreed to participate. Those subjects taking vitamin D supplements
or using ultraviolet lamps were excluded frcm the study.
Measurement of the following were made at monthly intervals between
December 1978 and December 1979: serum or plasma calcium,
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phosphate, magnesium, alkaline phosphatase, albumin, and 25-OHD.
A record was kept of holidkys "7 ""n-bathing activities.
Height, weight, and skinfold thickness were measured. A dietary
history for calcium and vitamin D was made by a Senior Dietician in
December 1979 using the method of 7-day recall. The number of hours
of sunshine at the Royal Botanical Gardens in Edinburgh were given
by the Meteorological Office.
Eh RESULTS.
1. Controls for TBCa.
a. Reasons for exclusion.
Nine patients were excluded from the
study for the following reasons: osteoarthrosis (3), anticonvulsant
therapy (2), wcmen with wrist fractures (2), alcoholism (1), and
coeliac disease (1). The two wcmen with wrist fracture were
included in the study of patients with wrist fracture.
b. Source of volunteers.
Twenty-nine of the volunteers worked in
the hospital, four in the local factory, four in the local police
station, and three had read or heard one of the two interviews.
c. Number of fractures.
Twenty-seven of the volunteers had never
sustained a fracture; the remainder had fractured the ankle (6),
wrist (3 men), clavicle (2), nose (2), jaw (1), finger (1), and toe
(1 ). No volunteer had fractured the hip or vertebra.
d. Total body calcium.
The TBCa in the men ranged from 886 to
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1428g with a mean of 1143g and SD of 134g (Figure 3a). The CV of
*-u-'c croup was 11.7% before normalization. The raietho~n for
normalization is given in the Appendix. The closest relationship
was found to be between TBCa and height with body weight and age
showing no significant relationship with TBCa. The formula for
predicting TBCa (TBCa^) was:




where, a was 347
H was height
TBCa can be expressed as a ratio of TBCa^ to give a calcium
ratio, or Ca^, as described by Cohn et al.(1974). The mean and SD
of Ca^ in the men were 1 .000 and 0.062. Thus by normalization the
CV of the male controls was reduced frcm 11.7% to 6.2% (Figure 3a).
The men from whom this formula was derived were aged 42 to 69 years
and were 1.64 to 1.90m tall.
The TBCa in the women ranged frcm 598 to 1036g with a mean of
821 g and SD of 124g (Figure 3b). The CV of this group was 15.2%
before normalization. The method used for normalization is given in
the Appendix. The closest relationship was found to be between TBCa
and span and TBCa and years postmenopause. Body weight showed no
significant relationship with TBCa. The formula for predicting TBCa
(TBCa^) in wcmen was:


















































Figure 3b. Total body calcium and calcium ratio in female controls.
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ypm was years postmenopause,
a was 399.
In the analysis it was assumed that the rate of bone loss
after the menopause was exponential. The estimated rate of bone
loss was 1.5%/year. This is shown in Figure 3c. In this Figure the
"1 £Q 1 £Q
term TBCa/a x S * is used. The expression a x S * predicts TBCa
from armspan for a woman at the time of the menopause and the
1 69
expression TBCa/a x S * will be referred to as the osteopaenia
index as it attempts to predict the amount of bone lost since the
time of the menopause.
The mean and SD for Ca^ in the wcmen was 1 .000 and 0.066
(Figure 3b). Thus the CV was reduced frcm 15.2% to 6.6% by
normalization. The wcmen from whcm this formula was derived were 0
to 22 years postmenopause and of armspan 1.50 to 1.75m.
e. Biochemistry.
The results are shown in Table 3a. The results of
plasma alkaline phosphatase and 25-OHD were logarithmically
transformed as their distributions were skewed. There was no
difference in plasma biochemistry between the men and women but the
men had higher 24-hour urinary excretion of phosphate (P<0.01)/
creatinine (P<0.001), and hydroxyproline (P<0.01). The men also had
higher creatinine clearance (P<0.001).
There was a direct relationship between 24-hour urinary
excretion of creatinine and lean body mass (r = 0.85, P<0.001) and
this is shown in Figure 3d. In other groups collections of urine
were considered incomplete if the urinary creatinine was outwith
the 95% confidence limits for a given lean body mass.
Plasma calcium and serum albumin were not closely related.
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Figure 3c. Osteopaenia index and years postmenopause in the female
controls.
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Table 3a. Biochemical results in the 60 control subjects ♦ Results are
expressed as mean (Su,. —?al comparisons are made using an unpaired
t-test between male and female TBCa controls.
Variable (units). TBCa - Male. TBCa - Female. 25-OHD - all.
Number 20 20 20
Plasma.
Alkaline phosphatase (u/1) 50 50 51
[loge~transformed] 3.91 (0.25) 3.91 (0.22) 3.94 (0.30)
Phosphate (mmol/1) 1.01 (0.16) 1.11 (0.16) 1.20 (0.17)
Calcium (mmol/1) 2.37 (0.06) 2.38 (0.09) 2.35 (0.12)
Corrected calcium (mmol/1) 2.37 (0.09) 2.35 (0.08)
Magnesium (nmol/1) 0.83 (0.09) 0.80 (0.05) 0.77 (0.06)
Albumin (g/1) 41.9 (3.1) 43.4 (2.9)
25-OHD (nmol/1) 31 36 20
[ loge~transformed ] 3.43 (0.41) 3.58 (0.61) 3.01 (0.57)
PTH (mcg/1) 0.16 (0.09)
Creatinine (nmol/1) 0.08 (0.01) 0.07 (0.01)
Urine.
Calcium (mmol/24hr) 5.75 (2.77) 4.70 (2.11)
Magnesium (mmol/24hr) 4.25 (2.15) 3.41 (1.32)
Creatinine (ntnol/24hr) 17.3 (3.8) 10.1 (1.5)
Hydroxyproline (mcmol/24hr) 339 (83) 258 (67)
Phosphate (nrool/24hr) 34.0 (11.2) 23.1 (7.7)
3fC3|C3|e
Creatinine clearance (ml/s) 2.36 (0.45) 1.76 (0.38)
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Figure 3d. Urinary creatinine and lean body mass in the male Jj»J_
and female controls.. The lines indicate the regression line
with 95% confidence limits.
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Thus when the standard formula given in the methods section was
_ j. i OV of the control group increased (Table 3a).
f. Age and body measurements.
These are shown in Table 3b. The
men had greater armspan, height, weight, and lean body mass than
the wcmen. This greater weight was not due to fat as the women had
greater percent body fat (P<0.01). No difference was shown between
the sexes in BMT or percent overweight.
2. Controls for plasma 25-OHD.
a. Reasons for exclusion.
Six patients were excluded from the
study. Four of these left the hospital, one took vitamin D
supplements, and one used an ultraviolet lamp.
b. Biochemistry.
The results of samples taken in 1979 are shown
in Table 3a. They had higher levels of plasma phosphate (P<0.02)
and lower levels of plasma 25-OHD (P<0.01) than the controls for
TBCa.
There was a marked seasonal variation in plasma 25-OHD as
shown in Figure 3e. The peak value occurred 6 weeks after the
maximum daily hours of sunshine. The maximum mean value of plasma
25-OHD occurred in July and was 43.1 nmol/1 and this fell to 22.7
nmol/1 in February.
Plasma 25-OHD increased by 2.5 times the basal value, on
average, following nine holidays spent sunbathing, compared with an
increase of only 1.4 times the basal value following six holidays
with no sunbathing.
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Table3 .Agndbodymeasurementsi controlsf rTBCaandplasma25-OHD.R ultsrexpres edan(S ). Statisticalcomparisonsa edeusi gaunpaired-t tbetwe nmalenfe aleTBCacontrolsdb tw enm le andfemale25-OHDcontrols. Variable(units).TBCa-Male.TBCa-Female.25-OHD-Male.
25-OHDFemale.
Number Age(yr) Postmenopause(yr) Armspan( ) Height(m) Weight(k ) Overweight(%) Bodymassindex(kgrrT^) Bodyfat(%) Leanbodym ss(kg)
-2,
20 54.4(8 8) 1.83(0.09)
*** ***
1.78(0.08) 81.8(11.3) 12.2(12.2) 25.8(3 ) 26.0(10.4) 59.8(7 0)
***






77.2(9 0) 5.9(11.6) 24.1(1 7) 19.4(9.4)' 61.9(4 3)
** ***
34.0(13.9 1.65(0.04) 60.2(4 3) 1.0(6.5) 22.0(1 4) 28.1(4 8) 43.2( 5)
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Figure 3e. Plasma 25-OHD in the controls and the number of hours of
sunshine per month in Edinburgh.
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There was no significant relationship between plasma 25-OHD
-? dietary vitamin D intake.
The results of plasma biochemistry grouped by season are shown
in Table 3c. The summer peak of plasma 25-OHD was associated with a
fall in plasma magnesium (P<0.02), a rise in plasma phosphate
(P<0.05), and an autumnal rise in plasma alkaline phosphatase
(P<0.05). The groups were ccmpared using a paired t-test. Periodic
regression analysis also showed significant cyclical variations in
plasma 25-OHD (P<0.001 ) and magnesium (P<0.05).
c. Age and body measurements.
These are shown in Table 3b. They
were 25 years younger, on average, than the controls for TBCa, and
had less body fat (P<0.01 for the wcmen).
d. Dietary history.
In 19 subjects the mean daily calcium intake
was 1280mg (SD, 360mg), and the mean daily vitamin D intake was
2.6microgram (SD, 1.2microgram). The recommended daily intake of
calcium is 500mg (DHSS) and only one volunteer took less than this.
0_ DISCUSSION.
1. Controls for TBCa.
The mean values of TBCa in men and women were
1143g and 821g, respectively. Two other groups have reported
absolute TBCa in healthy vounteers. In the report of Cohn et
al.(1976) the mean values for six men and ten wcmen aged 50 to 59
years were 996g and 804g, respectively. The controls in the present
study were taller than those of Cohn et al.(1976) , the men by 10cm
and the wcmen by 2cm and this would account for these lower values.
Nelp et al.(1972) measured eight men of mean age 34 years and
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found a mean TBCa of 1093g. These volunteers were 3cm shorter than
our own. The mean heigjfafc o 1 'inteers in the present study was
more than that in previous studies as they included 4 policemen.
These same two groups also normalize TBCa for body size. Nelp
et al.(1972) predict TBCa from (height)^. Cohn et al.(1976) predict
TBCa frcm age, height and total body potassium. This last
measurement is an assessment of lean body mass. In the present
study lean body mass did not improve the F-statistic in the
multiple regression analysis (see Appendix).
Armspan related to TBCa closer than did height in the female
volunteers of the present study. The use of armspan rather than
height allowed a fairer comparison with the wcmen with vertebral
fractures who lose height with each fracture.
The formula for predicting TBCa in wanen assumed an
exponential rate of loss of bone mass after the menopause and this
was calculated at 1.5%/year. Cohn et al.(1976) reported a rate of
loss of 1.1%/year in wcmen after the age of 55 years.
The rate of bone loss after the menopause may not be
exponential. Newton-John and Morgan (1970) reviewed 20
cross-sectional studies of changes in bone mass with age in wcmen
and they concluded that the loss was linear. Lindsay et al.(1978)
reported a rate of bone loss of 2.6%/year in the first four years
after bilateral oopherectomy and this subsequently fell to
0.75%/year. The menopause is only one event signalling a gradual
fall in plasma oestradiol levels. The further a wcman is away frcm
the menopause the poorer her memory of its exact timing.
Newton-John and Morgan (1970) also concluded that the rate of
bone loss after the age of 40 to 45 years in wcmen was 1%/year and
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after the age of 50 to 65 years in men was 0.6%/year. No
significant fall in bone mass with >va "" -n the men of the
present study.
Normalization of TBCa for body size and age lowered the CV of
the normal range to 6.2% in men and 6.6% in wcmen. Cohn et
al.(1976) reported CV after normalization of 7.8% in men and 7.1%
in wcmen. Thus a reduction of TBCa in a patient of more than 15%
below the mean can be detected with 95% confidence.
The age range of the controls is narrower than that of Cohn et
al.(1976) and so more caution is required when comparing groups.
For example, no woman was more than 22 years postmenopause. Thus
the formula for TBCa^ cannot be applied to wcmen past this age.
Half of the volunteers were more than 10% above their ideal
weight. This is representative of the British population. Baird et
al.(1974) reported that between the ages of 50 and 65 years 43% of
men and 50% of wcmen are more than 10% above their ideal weight. As
discussed above, the men were taller than the volunteers of Cohn et
al.(1976) and Nelp et al.(1972). They were also 4cm taller than men
of a similar age in the study of Baird et al. (1974). This may have
been due to inclusion of four police officers in our group.
Plasma concentrations of alkaline phosphatase, phosphate,
calcium, magnesium, creatinine and albumin were similar to those
previously reported by Ladenson (1980). The samples were collected
throughout the year and so would not be expected to show the effect
of season described below. The plasma PTH was below the effective
sensitivity of the assay in 50% of cases. This is a higher
proportion than that reported by Woo and Singer (1974) who found
that only 10% of their controls were below this level. The
- 46 -
statistical analysis of PTH results was made more difficult by this
■ v- rnethods used are given in the Appendix.
2. Controls for plasma 25-OHD.
The seasonal variation in plasma
25-OHD is well-known and the results from six other studies along
with the present one are shown in Table 3d. The action of
ultraviolet light on the skin contributes more vitamin D than does
the diet. The peak in plasma 25-OHD follows the maximum daily hours
of sunshine when the wavelengths 280 to 305 nm are contributing
most to ultraviolet light.
The plasma 25-OHD levels shown in Table 3d show surprisingly
little effect of latitude. The results for hospital workers living
in Tromso in Norway (69 ° North) are as high as those of nurses in
St.Louis in the U.S.A. (38 ° North). Foods such as milk and
margarine are fortified with vitamin D in the U.S.A., Australasia,
Denmark, Norway, and Sweden. Lund and Sorensen (1979) reported that
60% of the elderly population of Denmark take vitamin D supplements
in the winter. Such dietary factors may be important in towns such
as Trcmso, north of the Arctic Circle, where there is no daylight
for two months of the year. One further explanation may be
differences in assay technique. The proposal by Fraser (1983) that
diet is an unimportant source of vitamin D nay apply to Britain
where vitamin D fortification of food is less than elsewhere, and
where vitamin D supplements are not regularly taken by the elderly,
but it may not apply world-wide.
The summer rise in plasma 25-OHD is probably the cause of the






















































































rise in 25-OHD may cause increased calcium absorption with an
associated increased urinary c®Ilciu (Robertson et al.,
1974, Morgan et al., 1972). This would tend to increase plasma
calcium with a resulting fall in plasma PTH and rise in plasma
phosphate (Aitken et al., 1973, Frank and Carr, 1957, Iwanami et
al., 1959, Josephson and Dahlberg, 1952, Vik et al., 1980) and fall
in plasma magnesium (shown by Frank and Carr, 1957, but not by Vik
et al., 1 980). Osteomalacia would heal in response to the increased
plasma 25-OHD (Aaron et al., 1974) with a rise in bone mass (Aitken
et al., 1973) and a fall in plasma alkaline phosphatase (shown by
Devgun et al., 1981, and by Josephson and Dahlberg, 1952, but not
by Vik et al., 1980,or by McLaughlin et al., 1974).
The large seasonal changes in plasma 25-OHD make
season-matching of groups under study important. Throughout the
present study individual plasma 25-OHD are related to the reference
range for that month. Measurements were made only in winter and
spring in the studies of calcium metabolism after peptic ulcer
surgery and wrist fracture. For the other groups the plasma 25-OHD
was measured at presentation. The seasonal variation in other
biochemical measurements are taken into account in the
interpretation of data and explains the difference between the TBCa
control group (taken throughout the year) and the plasma 25-OHD
control group (taken in December).
The two to three-fold rise in plasma 25-OHD that follows a
vacation spent sunbathing confirms the unpublished results of de
Silva and Taylor quoted by Stanbury and Mawer (1978). In the
present studies patients were questioned about sunshine exposure.
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D. SUMMARY.
1. In 20 male volunteers aged 42 to 69 years the mean TBCa was
1143g with a CV of 11.7%. Total body calcium could be predicted
from height (TECa^). Calcium ratio (Ca^) was the ratio of observed
and predicted TBCa. The CV of Ca^ was 6.2%.
2. In 20 female volunteers aged 46 to 66 years the mean TBCa was
821g with a CV of 15.2%. Total body calcium could be predicted from
armspan and years postmenopause and the Ca^ calculated as for the
men. The CV of C^ was 6.6%.
3. Reference ranges were derived from the data of the healthy
volunteers for the following: plasma alkaline phosphatase,
phosphate, calcium, albumin, magnesium, PTH, 25-OHD; urinary
calcium, phosphate, magnesium, creatinine, and hydroxyroline; and
dietary intake of calcium and vitamin D.
4. A relationship between urinary creatinine and lean body mass was
described which allowed assessment of the completeness of urinary
collections.
5. Several measurements of body size were made to allow comparison
with other groups.
6. Monthly reference ranges were established for Edinburgh in 1979
and the seasonal variation and its relationship to numbers of hours
of sunshine was noted. The seasonal variation in plasma magnesium,
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phosphate, and alkaline phosphatase were described to show the
iimwart ~ 3son-matching of groups under study.




Fifteen wanen aged 48 to 71 years were
referred to the endocrine clinic for treatment of osteoporosis.
Back pain had been present for less than two years in 11 of these
women. All patients had two or more fractures present on a lateral
radiograph of the thoracolumbar spine.
A search was made for factors which may have accelerated bone
loss, such as malabsorption or renal failure, by clinical
examination and by the following investigations: serum or plasma
alkaline phosphatase, phosphate, calcium, magnesium, albumin, PTH,
25-OHD, creatinine, iron, iron-binding capacity, ferritin, vitamin
B12, folic acid, and thyroxine; full blood count; 24-hour urinary
excretion of calcium, phosphate, magnesium, hydroxyproline, and
creatinine; isotope bone scan and bone biopsy when indicated; and
TBCa.
Nine patients were treated with alphacalcidol
0.5micrograms/day, ethinyloestradiol 20 micrograms/day for 3 weeks
in every 4, and calcium supplements as calcium lactate gluconate
(Sandocal) 4 Tablets daily (equivalent to 40 mmol calcium/day).
Total body calcium and the above biochemical tests were repeated
after 9 months' therapy. The remaining six patients were unable to




Thirty women aged 45 to 75 years were recruited
from the fracture clinic. During the winter and spring of 1979
approximately 60 patients who had fractured their wrists in the
preceding month were invited to participate in a trial on the
effect of treatment on osteoporosis.
Blood was taken without tourniquet in the non-fasting state
for alkaline phosphatase, phosphate, calcium, magnesium, albumin,
FTH, 25-OHD, creatinine, thyroxine and full blood count. Calcium
and creatinine concentrations were measured on an early morning
specimen of urine.
Twenty-eight wcmen were allocated randcmly to one of the four
treatment groups.
1. Placebo (lactose 1 b.d.).
2. Ethinyloestradiol 20 micrograms/day, 3 weeks in 4.
3. Alphacalcidol 0.5 micrograms/day and Sandocal 2 b.d.
4. Treatments 2 and 3.
Forearm calcium and plasma biochemistry was measured at 0,
four, eight, and 12 months. Unfortunately, eight patients withdrew
frcm the study because of the side-effects of oestrogen such as
depression, breast discomfort, and anxiety about the potential
side-effects of oestrogen. Two patients in treatment group 4
changed to group 3 because of side-effects from the oestrogen. Only
six patients in groups 2 and 4 completed the study compared with 15
patients in groups 1 and 3. The results of the initial measurements
of patients in this group along with changes in the group given
placebo are described below.
- 53 -
TBCa was measured in six of the patients taking placebo and in
of the vounteers who had fractured their wrii«ts --<~fht
wcmen also had measurement of 24-hour urinary excretion of calcium,
phosphate, magnesium, hydroxyproline, and creatinine.
EL RESULTS.
1. Vertebral fracture group,
a. TBCa.
The mean and SD of TBCa in wcmen with vertebral
fracture were 649 g and 87 g. This was significantly lower than in
female controls (P<0.001).
The mean and SD of osteopaenia index were 0.69 and 0.06 and
the results are shown in Figure 4a. All the wcmen with vertebral
fracture had indices of 0.78 or below and thus had a deficit in
bone mass of more than 22% of the TBCa predicted for a woman of
similar armspan at the time of the menopause.
The formula for TBCa^ could not be applied to six of the wcmen
as they were more than 22 years postmenopause. In the remaining
nine the mean Ca^ was significantly reduced at 0.87 (SD, 0.06)
compared with controls (P<0.001), and this is shown in Figure 4b.
Factors which may have caused such reduction in bone mass were
identified in five of these nine patients. These were prednisolone
therapy for polymyalgia rheumatica, phenytoi.n therapy for epilepsy,
previous history of thyrotoxicosis, atrophic gastritis, and






























Figure 4a. Osteopaenia index in women with vertebral fracture (□),
women with wrist fracture (.:), and female controls (O). Broken



















Figure 4b. Calcium ratio in women with vertebral fracture (G),
women with wrist fracture (A), and female controls (O). Broken
lines indicate mean and 2SD of calcium ratio in female controls.
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b. Biochemistry.
These results are shawm £h " Ar where they
are compared with the results of the female controls for TBCa.
There was a significant reduction in creatinine clearance (P<0.02)
and five women with vertebral fractures had values below 1 ml/s (60
ml/min). The plasma PTH was elevated (P<0.02) but in no case above
the laboratory reference range. There was a significant reduction
in the serum albumin (P<0.01).
c. Age and body measurements.
These are shown in Table 4b where
they are compared with female controls for TBCa. Wcmen with
vertebral fractures were older and had had earlier menopauses than
controls. They also had shorter height for armspan due to their
fractures and this is shown in Figure 4c.
d. Effect of treatment.
The pre-treatment values for body
measurements, biochemistry, and TBCa are shown in Table 4c. The
nine wcmen who were treated had similar characteristics to the
whole group (Tables 4a and 4b).
Treatment had no significant effect on any biochemical
variable. The mean increment in TBCa of 2.1% over nine months
failed to reach significance.
2. Wrist fracture group,
a. TBCa.
The mean and SD of TBCa in women with wrist fracture
were 787g and 72g. This was not significantly different from female
controls.
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Table4 .Agndbodymeasur mentsiwom nithfracturesndif alecon rolsfTBCa.R sultsa eexpres ed asmean(SD).tatisticalcomparisonsweredeusi gunp iredt- tb w nfr tureti tsf male controls. Variable(units). Number Age(yr) Postmenopause(yr) Armspan( ) Height(m) Weight(k ) Overweight(%) Bodymassindex(kgm-') Bodyfat(%) Leanbodym ss(kg)Vertebralfractu e. 15 -2,** 64.7(6.9) ***21.9(8.4) 1.66(0.07) 1.57(0.08) 57.2(9.8) 5.0(15.3) 23.1( 2) 32.7(4.5) 38.3(5 9)Controls. 20 57.5 8.9 1 .65 1.61 63.3 10.6 24.2 35.5 40.5Wristfracture( ll), 30 59.7(5.8) 11.4(5 8) 1.62(0.06) 65.0(7.3) 13.5(12.1) 24.8(2.7)




















Figure 4c. Span minus height in five groups of wanen. Closed
circles indicate those wcmen who have suffered a vertebral
fracture.
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Table 4c. The effect of treatment on the results of wcmen with
vertebral fracture. Results are expressed as usaan
Variable (units). Initial measurement. Change.
Age (yr) 64.3 (7.2)
Postmenopause (yr) 23.2 (9.9)
Height (m) 1.57 (0.10)
Weight (m) 55.2 (10.9)
Duration of treatment (mths) 9.4 (2.7)
Plasma.
Alkaline phosphatase (u/1) 59 -8.7 (4.9)
Phosphate (mmol/1) 1.09 (0.15) -0.06(0.07)
Calcium (mmol/1) 2.38 (0.08) 0.03(0.04)
Magnesium (mmol/1) 0.82 (0.09) -0.01(0.04)
25-OHD (nmol/1) 43
PTH (mcg/1) 0.25 (0.08)
Urine.
Calcium (nmol/24hr) 3.36 (1 .47) 0.70(0.94)
Magnesium (mmol/24hr) 2.91 (0.93) -0.35(0.51)
Phosphate (nmol/24hr) 23.0 (9.0) -6.7 (5.8)
Hydroxproline (mcmole/24hr) 275 (95) -51 (49)
Creatinine clearance (ml/s) 1.49 (0.55)
IVNAA.
IBCa (g) 636 (108) 16 (10)
Ca^ 0.84 (0.07)
1 69
Osteopaenia index (g/ra * ) 0.68 (0.07)
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The mean and SD of osteopaenia index were 0.84 and 0.08, as
)#f3wn 4a. Three of the eight wcmen had values below 9U78
However, none of these wcmen had span - height values of more than
6 cm (Figure 4c).
The mean and SD for Ca^ were 1.00 and 0.10, and were therefore
no different from controls (Figure 4b).
b. Biochemistry.
These are shown in Table 4a where they are
compared with female controls for TBCa. The wcmen with wrist
fracture had significant elevations in plasma alkaline phosphatase
(P<0.001), magnesium (P<0.001), and PTH (P<0.02), and a significant
reduction in plasma 25-OHD (P<0.05). The blood samples were taken
between February and June 1979.
The initial results of plasma 25-OHD and the results frcm
samples taken at 4-monthly intervals thereafter in patients not
taking oestrogens (as they increase 25-OHD binding protein) are
shown in Figure 4d. Only three results fell below the reference
range and in each case plasma calcium and PTH were normal and in
two of the three alkaline phosphatase was normal.
In those patients given placebo there were falls over the
period of a year in plasma alkaline phosphatase, magnesium, and
PTH, but these changes were not satistically significant.
c. Age and body measurements.
These are shown in Table 4b where
they are compared with female controls for TBCa. The results of
those patients studied by TBCa are listed separately as the
remaining patients did not have armspan or skinfold thickness
measured. There were no significant differences between the wrist
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Figure 4d. Plasma 25-QHD in women with wrist fracture on no
treatment. The bars represent mean and 2SD after logarithmic
transformation of plasma 25-OHD values in controls.
- 63 -
fracture group and controls or between the wrist fracture group and
the subgroup studied by TBCa.
CL DISCUSSION.
1. Vertebral fractures.
The range of osteopaenia index in this group
was 0.60 to 0.78 and this suggests that they have a 22 to 40%
reduction in bone mass. Most of the wcmen had sustained their first
vertebral fracture recently and so a reduction in bone mass must
occur before this fracture occurs in a postmenopausal woman.
In a personal communication Dr. R. Hesp passed on the armspan
and TBCa measurements of 1 4 wcmen with vertebral fractures and who
were aged 56 to 81 years. The TBCa results had already been
published (Hesp et al.,1982). TBCa was measured by IVNAA using the
cyclotron at the Hammersmith Hospital, London, as the source of
neutrons (Spinks et al.,1977). The osteopaenia index was calculated
as described above and the mean and SD were 0.66 and 0.08, with all
cases below 0.80. Two women had values between 0.78 and 0.80. The
mean value was similar to that found in the present study of 0.69.
Although osteopaenia index has not previously been applied to
TBCa results the calcium bone index described by McNeill and
Harrison (1977) is a similar concept. They measured part-body
calcium (trunk and thighs) by IVNAA and express the result as a
proportion of that found in a subject of the same sex and height
under the age of 55 years. The mean and SD for controls of mean age
64 years were 0.88 and 0.13. In patients with osteoporosis of mean
age 56 years the corresponding results were 0.69 and 0.11. These
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results are similar to those of the present study in which the
\;~—'aonia index of female controls of mean age 58 years n
and that of wcmen with vertebral fractures was 0.69: Indices such
as calcium bone index and osteopaenia index may prove useful in
predicting which wcmen are likely to benefit from measures aimed at
prevention of loss of bone mass.
The low TBCa in these wcmen was partly due to early menopause.
If this were the only factor then Ca^ would have been the same as
for the controls. As it was 13% lower there must either have been
an increased rate of bone loss or a low bone mass at the time of
the menopause.
Two other groups have reported values of TBCa similar to those
found in the present study. Cohn et al.(1974) reported mean and SD
for TBCa of 688g and 94g. Nelp et al.(1972) reported mean and SD
for TBCa of 590g and 108g. Seme patients in the study of Cohn et
al.(1974) had only vertebral demineralization shown on the lateral
spine radiograph and no vertebral fractures. Nonetheless these
results are similar to the mean and SD described here of 645g and
87g. Cohn et al.(1974) also reported a mean Ca^ of 0.82, a result
lower than that of 0.87 described here. This descrepency may be due
to the higher rate of loss of bone mass found in the present study
and used in the equation to predict TBCa.
Factors known to accelerate bone loss were identified in seme
of the patients. The mean creatinine clearance was lower than that
found in controls and this may have been the reason for the
increase in plasma FTH. Lemann et al.(1979) have shown that when
creatinine clearance falls below 50 to 80 ml/min (0.83 to 1.33
ml/s) the plasma PTH rises. Half of the wcmen with vertebral
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fracture had creatinine clearance below these values. This
secondary bysssrpa ' Ksirlism my have accelerated bone loss. The
mild renal impairment may also have affected the synthesis of
calcitriol, the form of vitamin D most active in promoting calcium
absorption in the gut.
The low bone mass of wcmen with vertebral fractures is not
the only factor which predisposes to fracture. In the patients with
hyperparathyroidism described in chapter 5 low osteopaenia indices
were found in the absence of vertebral fractures. This is also true
of the wcmen with osteomalacia described in chapter 6.
Frost (1981 ) proposed that osteoporosis was caused by low bone
turnover which allowed bone matrix to age and become more brittle.
Aaron (1977) described a similar defect found in histological
sections of bone from patients with osteoporosis and she termed
this defect "autoclasis". Similarly, Ralis (1983) describes a bone
quality defect that can be detected more commonly in elderly
subjects with femoral neck fracture than in elderly controls. This
defect can be demonstrated by microradiography, by tetracycline
labelling of decalcified bone, or by undecalcified bone which is
shattered by the microtome in an abnormal manner. Although Ralis
has not studied wcmen with vertebral fracture it is possible that
such a bone quality defect is also present in this group.
TBCa measurements have good reproducibility and this technique
has been used by others to describe small changes in bone mass
following therapy for osteoporosis (eg. Chesnut et al., 1977). In
the present group the numbers were so small that the rise in bone
mass found was not sigificant. No control group was used as all
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patients were referred for therapy of osteoporosis and Marshall and
Nordin (1977) had shown that the fib " here was effective in
making the calcium balance positive in osteoporotic wcmen.
2. Wrist fractures.
The osteopaenia indices and Ca^ in this group
were similar to the age-matched and sex-matched controls. Nordin et
al.(1980b) have shown a reduction in trabecular bone volume in the
iliac crest between the ages of 55 and 65 years. Trabecular bone
contributes much less to TBCa than cortical bone. It may be that
those wcmen who fracture their wrists lose trabecular bone faster
than cortical bone. The distal radius contains a higher proportion
of trabecular bone than elsewhere in the skeleton (about 50%) but
changes in the iliac crest may not reflect changes in the distal
radius.
These wcmen were unfortunate in slipping on the ice during a
particularly cold winter and had the controls fallen similarly they
too may have fractured their wrists. This would explain why the
TBCa did not differ between these two groups. A further factor may
be obesity. Twenty-seven of the 30 wcmen with wrist fractures were
above their ideal weight and this weight would be transmitted
through the wrist during a fall onto the outstretched hand.
The slight increase in plasma alkaline phosphatase shortly
after the fracture may be due to fracture healing. In the
placebo-treated group plasma alkaline phosphatase fell over the
following year. In patients with femoral neck fracture plasma
alkaline phosphatase rises to a peak of up to five times the basal
value about four weeks after the fracture (Sharland and Overstall,
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1978). The other biochemical differences frcm controls were
probably seasonal as the blood samples of the wrist fracture group
were taken between February and June (see Chapter 3). Plasma 25-OHD
followed the normal seasonal cycle and in this respect differ frcm
women with femoral neck fracture who have low levels (Lund et al.,
1975).
Dj_ SUMMARY.
1. In 1 4 wcmen who had recently sustained a spontaneous vertebral
fracture the mean TBCa was reduced to 649g. The mean Ca^ was also
reduced to 0.87 indicating that the low TBCa was not due to the
effect of age alone.
2. TBCa was adjusted to allow for body size alone (osteopaenia
index) in order to try and establish a theoretical fracture
threshold. All patients had osteopaenia indices below 0.78. When
this index was calculated for the data of Hesp et al.(1982) all
their patients with vertebral fractures had values of 0.80 or
below.
3. In the wcmen with vertebral fractures there was a reduction in
mean creatinine clearance and an associated rise in plasma PTH. The
renal impairement and the hyperparathyroidism may have accelerated
the rate of bone loss. In seme individuals diseases or drug therapy
likely to accelerate the rate of bone loss could be identified.
4. In 8 wcmen who had fractured their wrists the mean TBCa was
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787g. This was no lower than controls, and the mean was also
normal.
5. Patients with wrist fracture show the normal seasonal variation
in plasma 25-OHD. There was an initial increase in plasma alkaline
phosphatase, magnesium, and PTH, but these returned towards normal
over the year folowing the fracture.
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CHAPTER 5. PRIMARY HYPERPARATHYROIDISM.
A. PATIENTS.
Fourteen patients with primary hyperparathyroidism were
referred to the endocrine clinic between 1978 and 1982. Two of
these patients were identified in the screening tests performed on
other groups in the present study, one wcman with wrist fracture
and a man following Polya partial gastrectomy.
In addition to clinical examination the following measurements
were made: height, armspan, weight, skinfold thickness; plasma
alkaline phosphatase, calcium, magnesium, albumin, PTH, 25-OHD,
creatinine; discriminant function analysis was performed by the
method of Watson et al.(1980) frcm plasma phosphate, urea,
bicarbonate, chloride, and erythrocyte sedimentation rate; the
renal threshold for phosphate was calculated by the method of
Bijvoet (1977) frcm measurements of plasma and urinary phosphate
and creatinine made in the fasting state on a two-hour collection
of urine; 24-hour urinary excretion of calcium, phosphate,
magnesium, hydroxyproline, and creatinine; hydrocortisone
suppression test performed by the method of Dent and Watson (1968);
radiograph of hands; and TBCa. TBCa, and plasma and urinary




The complications of primary
hyperparathyroidism found in this group are shown in Table 5a. The
clinical examination also identified conditions likely to
accelerate bone loss in four patients. These were diabetes mellitus
(2), rheumatoid arthritis (1), and peptic ulcer surgery (1).
Ten of 11 patients underwent successful neck exploration. The
adenomata weighed between 0.17 and 1,59g. In the patient with the
unsuccessful neck exploration a venous sampling study suggested the
adenoma was in the mediastinum. However the adencma was not found
at a second, sternum-splitting operation. Of the three patients who
have not undergone surgery one refused surgery and two were
considered not to require surgery as the hypercalcaemia was mild.
Hand radiographs showed subperiosteal erosions in one patient
only.
2L TBCa.
The mean and SD of TBCa in the 11 women with primary
hyperparathyroidism were 664g and 119g. This was 19% below the
result for age- and sex-matched controls. In the men the mean value
was 1061 g.
The mean and SD of osteopaenia index in the wcmen were 0.73
and 0.12 (Figure 5a). Seven of the 11 wcmen had values below 0.78,
the level below which spontaneous vertebral fractures were found
(Chapter 4). Only one of these had back pain, loss of height, and
radiological evidence of vertebral fracture. The span - height
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Figure 5a. Calcium ratio and osteopaenia index in men (O) and women
(9) with primary hyperparathyroidism. Solid lines represent mean
and 2SD of calcium ratio in controls. The broken line indicates the
theoretical fracture threshold. The asterisk indicates the patient
with vertebral fracture.
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values in eight of the remaining ten women were less than 6cm, the
value above which vertebral fractures viciv. associated (Figure 4c).
Ten of the 11 wcmen were less than 22 years postmenopause and
so the formula for TBCa^ could be applied. The mean and SD of Ca^
were 0.81 and 0.11 (Figure 5a). This highly significant reduction
(P<0.001 ) was still found when the data from the patients with
rheumatoid arthritis and diabetes mellitus were excluded.
There was no significant relationship between Ca^ and plasma
calcium or alkaline phosphatase. The six patients with subnormal
Ca^ did not have higher plasma alkaline phosphatase than those with
normal Ca^.
In the seven patients remeasured after parathyroidectomy there
was a mean rise in TBCa of 49 g. This rise did not reach
significance. The least significant change using TBCa is 5.1%. Four
patients had rises above this (range 7.2 to 20.4%, see Figure 5c).
Only one of these patients had an elevated plasma alkaline
phosphatase.
3. Biochemistry.
The results are shown in Table 5b where they are
compared with those from the 40 controls for TBCa. There was a
significant elevation in plasma alkaline phosphatase compared with
controls (P<0.001 ) and this difference remained even when the
result from the patient with subperiosteal erosions was excluded
from the comparison. Three patients had values above the laboratory
reference range. There were also significant elevations in plasma
magnesium and PTH and in urinary calcium (P<0.01, P<0.001, and
P<0.02, respectively). There was elevation of plasma calcium and
detectable or elevated PTH in all cases as shown in Figure 5b.
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Table 5b. Biochemical results in patients with primary
hyperparathyroidism. Results are expressed as mean (SD) and
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Figure 5b. Plasma PTH and calcium in the TBCa controls (small
circles) and in patients with primary hyperparathyroidism.
Patients with surgically-proven adenomas are represented by open
circles. Broken lines represent mean and 2SD of the results from
TBCa controls. The solid line represents the lower limit of
sensitivity of the PTH assay.
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There was a significant reduction in plasma phosphate (P<0.001 ).
•—-im-inant function analysis correctly classify®
patients in 12 cases. The patient with subperiosteal erosions was
not classified correctly nor was the one patient who refused
surgery.
The mean TMP/GFR was 0.68 mmol/1 (SD, 0.25) and five out of
eight patients had low values. Five out of six patients showed no
suppression of plasma calcium during the hydrocortisone suppression
test. The remaining case underwent a PTH catheter study which
suggested an adencma in the thymus. As the hypercalcaemia was mild
operation was deferred.
Seven patients were remeasured six to 32 months
post-operatively. In all cases plasma calcium fell to normal or low
(1 case). There were significant falls in plasma calcium (by 0.34
mmol/1, P<0.001), and in magnesium (by 0.09 mmol/1, P<0.05), and a
significant rise in plasma phosphate (by 0.26 mmol/1, P<0.05). The
mean fall in plasma alkaline phosphatase of 26 u/1 did not reach
significance.
4. Age and body measurements.
These are shown in Table 5c where
they are compared with the female controls for TBCa. The 11 wcmen
were of similar chronological and postmenopausal age and similar
body size to the female controls. The three men were more
overweight than the male controls, and one of the men was obese
(49% above ideal weight).
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Table5c.Agndbodymeasurementsi patienwithhyp rparathroidismife ale controlsfTBCa.Resultsa eexpres edm an(SD). Variable(units).Femalep tients.Controls.M lepatients. Number11203 Age(yr)54.5(10. )57 58 Postmenopause(yr)7.8(9.2)8 9 Armspan( )1.63(0.06)1 651.82 Height(m)1.58(0.06)1 611.73 Weight(k )59.8( 6)63.386.5 Overweight(%)8.8(17.8)0 627 Bodymassindex(kgm-2)23.9( 824.28.9 Bodyfat(%)33.8(4 9)35.525.7 Leanbodym ss(kg)39.2(4 5)40.564.2
C. DISCUSSION.
There has been one previous study of absolute
measurements of TBCa in patients with primary hyperparathyroidism.
Cohn et al.(1973) measured eight such patients and they had a mean
Ca^j of 0.89, a result similar to that of 0.85 found in the 14
patients described here.
Bone mass has been measured in this group of patients using
other techniques. Genant et al.(1973) found a 13% reduction in bone
mass in 65 patients using photon absorptiometry of the third digit.
Dalen and Hjern (1974) found a 10% reduction in 10 patients using
X-ray spectroscopy of the radius and ulna. Pak et al.(1975) divided
their 30 patients into postmenopausal wcmen and others (men and
premenopausal wcmen). Bone mass was measured by photon
absorptiometry of the radius. In the postmenopausal wcmen it was
reduced by 22% and in the others it was normal. Seeman et al.(1982)
described a reduction in lumbar spine and radius density using
double and single photon absorptiometry. The midradius density was
normal and this suggests that trabecular bone is affected more than
cortical bone.
Osteopaenia is thus a common feature of primary
hyp>erparathyroid ism, particularly in the postmenopausal woman.
Dauphine et al.(1975) reported an increased incidence of vertebral
fracture in such patients. More than half the patients in the
present study had osteopaenia indices less than 0.78 and yet only
one sustained vertebral fracture. This is discussed in Chapter 4.
Figure 5c shows the changes in TBCa in the seven patients of
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and the seven patients of Hosking et al.(1972). The mean change in
TBCa these —Ter an average period of 15 months was a
rise of 1.6%. The 95% confidence intervals of this change were
-2.1% to 5.3%. Thus even if a larger series were able to show a
significant rise it is unlikely that this would be more than 5.3%.
Only two of these 1 9 patients had radiological changes of primary
hyperparathyroidism and these two had rises of 12 and 16%. Although
little change in bone mass may occur in patients with no
radiological abnormalities this may not be the case in the small
group of patients with abnormalities.
Genant et al.(1973) found a seven percent rise in X-ray
spectrophotometry of the third digit one to three years
post-operatively. Nine percent of their patients had subperiosteal
erosions and 34% raised plasma alkaline phosphatase. In most series
of patients with primary hyperparathyroidism only 10 to 20% of
patients have elevated alkaline phosphatase.
Dalen and Hjern (1974) found a four percent increase over one
year using the mean result of changes in X-ray spectrophotometry at
seven sites in ten patients. No patient had radiological changes of
primary hyperparathyroidism.
These studies show that primary hyperparathyroidism causes a
substantial reduction in bone mass, particularly in the
postmenopausal woman. In the absence of radiological evidence of
osteitis fibrosa there is only partial recovery of this deficit
following surgery. It is likely that early surgery would prevent
osteopaenia but as primary hyperparathyridism is a common disorder
in the postmenopausal woman a randomized trial of surgery in women
without radiological changes of hyp>erparathyroidism is needed.
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The clinical features and biochemical findings are similar to
those reported by others (Tta " .Botts, 1978, and Paterson,
1974). There are two findings which are relevant to the
interpretation of results frcm the patients after peptic ulcer
surgery, as described in Chapter 8.
Plasma magnesium was higher in patients with primary
hyperparathyroidism than in controls and fell following
parathyroidectomy. Nordin (1976) described reduced urinary
magnesium excretion in primary hyperparathroidism. These results do
not agree with those of Mallette et al.(1974) or of King and
Stanbury (1970) who found hypcmagnesaemia in 14 and 19% of cases of
primary hyperparathyroidism, respectively. They did not report
changes with surgery.
Assay of plasma PTH is troublesome as this hormone exists in
various forms in the blood. Even though the assay used in the
present study is directed mainly against the N-terminal end of PTH
most of what is measured is probably inactive. Fenton et al.(1978)
report an upper limit of normal of 30 ng/1 for plasma PTH using a
cytochemical bioassay whereas the upper limit of normal of the TBCa
controls in the present study was 330 ng/1. The differences between
the antisera of the different assays was shown by Raisz et
al.(1979) who used four assays on sera frcm the same patients with
primary hyperparathyroidism and found that the percent of cases
with elevated PTH varies frcm 27 to 87. In the present study 8 of
the 14 patients had elevated PTH.
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4. SUMMARY.
1. In 14 patients with primary hyperparathyroidism there was a
reduction in Ca^ to a mean of 0.85. Only one of these patients had
radiological evidence of hyperparathyroidism.
2. The osteopaenia index was lower than the theoretical fracture
threshold in seven out of the eleven women. However, only one had a
vertebral fracture.
3. Following removal of the parathyroid adenoma four out of seven
patients had significant rises in TBCa. The mean increase in TBCa
of the group of 49g and was not significant.
4. The biochemical changes showed no relationship to the changes in
TBCa. The changes in plasma calcium and phosphate were as expected,
but the fall in plasma magnesium from an initially high value was a
new finding.
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CHAPTER 6. VTOMEN WITH OSTEOMALACIA.
Aj_ PATIENTS.
Seven women with osteomalacia were referred to the
endocrine clinic. All patients had malabsorption syndrome and their
diagnoses are shown in Table 6a. The diagnosis of osteomalacia was
based on the typical biochemical changes of hypocalcaemia and
hyperphosphatasia which responded to vitamin D therapy, or on the
typical bone biopsy changes.
Measurements were made of the following prior to initiation of
therapy with vitamin D: plasma calcium, phosphate, magnesium,
alkaline phosphatase, 25-OHD, PTH; urinary calcium and creatinine;
radiological skeletal survey; and TBCa.
Treatment with vitamin D depended on the policy of the
physician in charge of case. Five patients received vitamin
300,000 units intramuscularly at intervals according to the
biochemical response, one patient received oral vitamin 50,000
units weekly, and one patient received alphacalcidol 1 microgram
per day.
Repeat biochemical measurements were made in all patients




osteomalacia were 596 g
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SD of TBCa in the seven wcmen with
and 75 g. This was 27% below the mean for
Table 6a. Causes of osteomalacia in seven women.
Patient Age. Cause.
no.
38 Crohn's disease (for 15 years).
Small bowel resection (2 months previously).
71 Vagotomy and gastroenterostomy (8 years previously)
Bacterial colonization.
82 Polya partial gastrectomy (27 years previously).
64 Crohn's disease (for 21 years).
Vagotomy and pyloroplasty (12 years previously).
84 Vagotomy and gastroenterostomy (22 years
previously).
63 Malabsorption syndrome of undetermined cause.
69 Crohn's disease (for one year).
Right hemicolectomy (one year previously).
Polya partial gastrectomy (one year previously).
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female controls.
The mean and SD of osteopaenia : v. ~ n 17 and 0.08 and
this is shown in Figure 6a. Six of the seven women had osteopaenia
indices below 0.78, the level below which vertebral fractures
occur. However, the patients did not complain of back pain or loss
of height and had normal (span - height) values (see Figure 4c). A
lateral radiograph of the lumbar spine of patient number four is
shown in Figure 6b. The results of quantitative bone histology on
this patient are shown in Table 6b. The excess osteoid is a feature
of osteomalacia but the trabecular bone volume was high. The
osteopaenia index in this patient was 0.69.
Ca^ could not be calculated as five of the women were more
than 23 years postmenopause. None of the patients had Looser's
zones.
Three patients had repeat measurements of TBCa and their
results are shown in Table 6c. The increases were 4, 7, and 18%,
the largest rise being associated with the greatest fall in
alkaline phosphatase.
2. Biochemistry.
The results are shown in Table 6d where they are
compared with reference ranges derived frcm the results of the
female controls for TBCa. All patients had hyperphosphatasia and
hypocalcaemia. One patient received low-dose vitamin D before the
first measurement and she had a low-normal 25-OHD and a normal PTH
(patient no.4). All others had plasma 25-OHD values which were low,
or at the lower limit of the reference range for that month, and
PTH which was high, or at the upper limit of the reference range.



















Figure 6a. Osteopaenia index in women with osteomalacia compared
with women with vertebral fracture and female controls. Broken
lines indicate mean and 2SD of calcium ratio in female controls.
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Figure 6b. Lateral radiograph of the lumbar spine in patient
with osteomalacia.
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Table 6b. Quantitative histology of bone in patient no. 4 with
osteomalacia.
Variable. Value. Reference range.
Trabecular bone volume (%) 21.2 10.7 - 19.9
Osteoid volume (%) 33.2 0.9 - 2.3
Osteoid surface (%) 87.5 4.7 - 12.5
Osteoid index 37.9 16 - 21
Resorption surface (%) 10.5 2.6 - 4.4
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MEAN4.890. 52 0191.8650 48.2 SD0.25311. 61 0070.47.
hypocalciuria. Although they had significantly lower urinary
C P<0. en? ()
creatinine than controls t -■ - . M'S was appropriate for their
low lean body mass (see Figure 3a).
The effects of treatment are shown in Table 6c. In five
patients the plasma calcium and alkaline phosphatase fell into the
reference range. The remaining patient (patient number one) had a
flare-up of her Crohn's disease with weight loss during her
11-month follow up period.
3. Age and body measurements.
The results are shown in Table 6e.
They were older by 10 years and lighter by 16 kg when compared with
the female controls. The reduction in weight was due to a reduction
in both body fat and lean body mass. They were, on average, 16
years more past the menopause than the female controls and the mean
armspan was 5 cm less. The two latter factors would usually be
associated with a reduction in TBCa.
Ch DISCUSSION.
The low values of TBCa and osteopaenia index in the
wcmen with osteomalacia was due in part to the long time interval
since the menopause (mean, 24 years). The contribution of this
factor could not be assessed by the equation for TBCa^ as most of
the wcmen were more than 22 years postmenopause. Back pain and loss
of height were not complaints in this group and this is confirmed
by the normal (span - height) values shown in Figure 4a.
Patient number four illustrates this point well and the
results of her quantitative bone histology and a photograph of the
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Table 6e. Age and body measurements in worasn '—^lacia and










Body mass index (kgm )
Body fat (%)
















lateral lumbar spine radiograph are shown in Table 6b and Figure
£b» This patient had an osteopaenia index of 0.69, a
the threshold found for women with spontaneous vertebral fracture,
yet no vertebral fracture is present. The bone biopsy shows excess
osteoid but high trabecular bone volume. As vertebrae are composed
of 50% trabecular bone they may be less affected by osteopaenia
than other bones which are composed of more cortical bone. This
case illustrates that TBCa measurement only gives a rough guide to
the bone mass of the vertebrae and that in bone disease that
affects cortical bone more than trabecular bone the result may be
misleading.
There are few reports on bone mass in patients with
osteomalacia. Morgan et al.(1970) reported metacarpal cortex
thickness in 17 of their 23 patients with osteomalacia following
gastric surgery and they had lower values than age- and sex-matched
controls after gastric surgery without osteomalacia.
Hosking et al.(1972) measured TBCa in six patients for six to
36 months following treatment. Increases in TBCa ranged from three
to 30%. In the present series changes of four to 18% were found
over three to 11 months in three patients.
The diagnosis of osteomalacia on biochemical grounds alone can
be difficult. Paterson (1974) considers that hypocalcaemia,
hypophosphataemia, and hyperphosphatasia are usually, but not
always present in osteomalacia. Nordin et al.(1980) consider that a
low plasma 25-OHD along with a raised plasma PTH signify
osteomalacia. Table 6c shows that most of these biochemical
abnormalities were present in most of the patients.
Confirmation of the diagnosis may be by the finding of
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Looser's zones on the radiological survey, the response of
biochemical rrra and bone mass to vitamin D therapy, or the
presence of excess osteoid and reduced bone formation rate in the
bone biopsy. None of the patients in the present study had Looser's
zones. Five of the six patients followed for up to 25 months showed
return of plasma calcium and alkaline phosphatase to the normal
range; the remaining patient had active Crohn's disease during the
follow-up period and weight loss. Three patients had bone biopsies
and each of these confirmed the diagnosis.
Looser's zones are present only in advanced cases of
osteomalacia and bone biopsy is a painful procedure that may
necessitate a general anaesthetic. As patients with osteomalacia
are ccmmonly old and frail the third method for diagnosing
osteomalacia is preferable. Thus in Chapter 8 the diagnosis of
biochemical osteomalacia is based on the abnormal biochemical
findings listed above which return to normal one year after vitamin
D therapy with an associated rise in bone mass.
Osteomalacia was due to malabsorption syndrcme in all cases.
This reflected the referral practices within the hospital. Most
patients were old and all were wcmen and this follows the pattern
found in an Edinburgh study more than 10 years previously by
Chalmers (1968).
Meredith and Rosenberg (1980) reported that 5% of patients
with Crohn's disease have osteomalacia, and that 70% have lew
25-OHD levels. This may be due to the depletion of the bile salt
pool in this condition when it affects the terminal ileum. Bile
salts facilitate the absorption of vitamin D. Although dietary
vitamin D is not the major source of vitamin D the depleted bile
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salt pool may affect the normal enterohepatic circulation of
vitamin D> an ..." ites.
Of the 93 patients described by Chalmers (1968), 32 had
undergone partial gastrectomy. Osteomalacia has been described
after vagotomy and pyloroplasty (Mitchell et al., 1971) but not
after vagotomy and gastroenterostomy. Two patients in the present
study had this latter operation and one of these had bacterial
colonization of the stomach that responded well to antibiotics.
Eh_ SUMMARY.
1. The mean TBCa in seven women with osteomalacia was 596g, and was
27% lower than the mean for female controls.
2. Six out of seven patients had osteopaenia indices below the
theoretical fracture threshold, but none had vertebral fractures.
3. Changes in TBCa following treatment ranged from 4 to 18%, the
largest change was associated with the largest fall in plasma
alkaline phosphatase.
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CHAPTER 7. RENAL TRANSPLANTATION.
/U PATIENTS.
Eight men and 4 wcmen aged 20 to 51 years
(mean, 35.9) were studied. They had been on maintenance
haemodialysis for 4 to 54 months (mean, 23). The causes of renal
failure were chronic glcmerulonephritis (6), polycystic kidney
disease (2), chronic pyelonephritis (1), obstructive nephropathy
(1 ), malignant hypertension (1 ), and Goodpasture1s syndrcme (1).
Two patients had hypercalcaemia due to secondary
hyperparathyroidism at the time of operation, one had
aluminium-induced osteomalacia, and one had osteomalacia treated
with alphacalcidol.
Nine patients received kidneys frcm cadavers and three frcm
related donors. Anti-rejection treatment was given as described by
McGeown et al. (1977). Azathioprine was given at a dose of 3
mg/kg/day and prednisolone at a dose of 20 mg/day. Subacute
rejection episodes (average of 1 per patient, range 0 to 3) were
treated with prednisolone 200 mg/day and reduced to 20 mg/day over
10 days. This dose was reduced to 10 mg/day over 10 to 33 months
unless chronic rejection developed (2 cases) and then the dose was
increased to 20 mg/day.
Initial measurements of TBCa were made in the week prior
to surgery in the three patients receiving kidneys frcm related
donors, and within 8 weeks of surgery in the remainder. Subsequent
measurements were made at about 6-monthly intervals for up to 33
months (mean, 17 months).
Plasma calcium values were available immediately prior to
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operation and were subsequently measured monthly along with
magnesmu v ?->d creatinine. Plasma phosphate values were
also available from before operation. Plasma PTH and 25-OHD and
urinary calcium, magnesium, phosphate, hydroxyproline, and
creatinine were measured when the initial TBCa measurement was




Initial values for TBCa and Ca^ are shown in Table 7a. The
mean initial Ca^ values in the 8 men showed a 7% reduction below
the mean for male controls and in the 4 wcmen an 18% reduction
below the mean for female controls. Three of the four wcmen and two
out of the eight men had Ca^ values less than 2 SD below the mean
for the controls.
The two men who underwent parathyroidectomy 4 and 20 months
after renal allotransplantation had increases in TBCa of 66g (8%)
over 10 months and 29g (3%) over 18 months, respectively. In the
remainder the mean change was calculated from the initial and final
measurements and was - 0.9%/year, with 95% confidence intervals of
-3.2 to 1.4%/year (Figure 7a).
2. Biochemistry.
The initial bichemistry results are shown in Table
7b and 7c. The elevated plasma creatinine fell gradually but never
into the normal range (Figure 7b). Two patients underwent
p>arathyroidectcmy and so their data are excluded from the following
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"fable 7a. Initial TBCa results in patients undergoing renal
transplantation.
TBCatg). MEM WOMEN
Renal failure. 1006 685
Controls. 1143 821
fag.
Renal failure. 0.93 0.82
Controls. 1.00 1.00
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Figure 7a. Changes in calcium ratio in men (9) and wcmen X®JL
following renal transplantation. Broken lines indicate mean and 2SD




The plasma alkali hase and phosphate (Table 7c) and
plasma magnesium (Figure 7c) all fell into the normal range. Plasma
calcium gradually increased over the first 6 months such that the
mean value was at the upper limit of the reference range for the
30-month follow-up period (figure 7c). The plasma PTH was elevated
even in the presence of hypercalcaemia (Figure 7d). These high
plasma PTH levels were associated with low creatinine clearances as
shown in Figure 7e where they are compared with the results frcm
male and female controls (for TBCa).
3. Age and body measurement.
This group was younger than the
oontrols for TBCa (Table 7d). They were also lighter due to a
reduction in body fat.
4. Radiology.
Seven out of the 12 patients had ectopic calcification.
This was confined to the arterial wall except in one case with a
calcified abdominal lymph node. In one patient radiographs of the
hand were taken annually for four years and there was no
progression in the arterial calcification despite persisent
hypercalcaemia.
- 101 -
Table 7b. Initial biochemical values in patients undergoing renal
transplantation. Statistical comparison was made using an unpaired
t-test.
Measurement (units). 12 PATIENTS. 40 CONTROLS.
Mean (SD) Mean (SD)
Plasma.
Alkaline phosphatase (u/1) 73.2 49.4
[loge transformed] 4.29(0.62) 3.90(0.23)
Phosphate (nmol/1) 1.80(0.50) 1.05(0.17)
Calcium (rrmol/1)1 2.43(0.31 ) 2.38(0.07)
Magnesium (mmol/1) 1.25(1.27) 0.81(0.05)
25-OHD (nmol/1)2 16.5 33.5
[log transformed] 2.80(0.52) 3.51(0.51)
PTH (mcg/1) 0.98(0.92) 0.16(0.09)
Creatinine (nmol/1) 0.52(0.47) 0.08(0.02)
Urine.
Calcium (mmol/24hr) 0.83(0.56) 5.20(2.46)
Magnesium (mmol/24hr) 3.7 (2.5) 3.8 (1.8)
Phosphate (nmol/24hr) 15.5 (13.9) 28.1 (10.8)
Creatinine (mmol/24hr) 10.9 (5.6) 13.2 (4.5)
Hydroxyproline (mcmol/24hr) 298 (118) 294 (84)
Notes.
1. These measurements were made pre-operatively in all cases.
2. Two out of 12 patients had low 25-OHD compared with
season-matched controls.
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Figure 7b. Changes in mean plasma creatinine and in mean daily dose
of prednisolone in patients following renal transplantation. Broken
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Months post-op
Figure 7c. Changes in mean plasma calcium and mean plasma magnesium
in patients after renal transplantion. Broken lines indicate
laboratory reference ranges. The results exclude the data from two
















Figure 7d. Plasma PTH and calcium in men (0) and women (JB]_














□ma orm o 0o o o
10 20 30 nils
Figure 7e. Plasma PTH and creatinine clearance in men (•) and women
after renal transplantation compared with male (O) and female
TBCa controls.
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Table 7d. Age, duration on haemodialysis, and body measurements in
patients undergoing renal transplantation. Statistical comparisons
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The annual reduction in T5KS; 0 was not
statistically significant and was much smaller than the 7% fall in
metacarpal bone density described by Lindsay et al.(1976). Aird and
Pierides (1977) showed a 5.1 to 5.4%/year fall in lower femur
density in the first year after renal transplantation. Both groups
used a higher dose of steroid and this could account for the more
rapid bone loss compared with the changes in the present study.
The insignificant change in TBCa contrasts with the
dramatic biochemical changes. The time-course of the return of
plasma alkaline phosphatase, phosphate, and magnesium to normal,
along with a reduction in plasma PTH almost to normal, corresponds
with the bone biopsy findings of Bortolotti et al.(1977). They
showed that the marrow fibrosis, excess osteoid, and increased bone
resorption had resolved by 16 to 20 months after renal
transplantation.
Ihe persistent mild hypercalcaemia has been described in 21%
of the 386 patients reported by Chatterjee et al.(1976), David et
al.(1973), Ibels et al.(1978), and Lee et al.(1973). It is
associated with normal or raised plasma PTH levels (Kleerekoper et
al., 1975). This elevation may be due to the persistently impaired
renal function (Figure 7e). Lemann et al.(1979) have shown that
plasma PTH rises when creatinine clearance falls below 50 to 80
ml/min (0.83 to 1.33 ml/s).
The initial low TBCa differs from the findings of others.
Cohn et al.(1975) and Denney et al.(1973) reported normal mean TBCa
values in patients on haemodialysis. The type of bone disease was
reported to affect TBCa, the lowest values being found in those
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with osteomalacia and normal or high values in those with
hyperparath"r^-!^ism. In the present series the low TBCa may have
been due to a higher frequency of osteomalacia but unfortunately
bone biopsies were not performed.
The healing of renal osteodystrophy after renal
transplantation might be expected to be associated with an increase
in TBCa, particularly in the patients with a predominantly
osteomalacia type of bone disease. In the present series this
effect was countered by the osteopaenic effect of the steroids.
Ectopic calcification was present in more than half the subjects
but was almost always confined to blood vessel walls and was
unlikely to have contributed much to TBCa (Denney et al., 1973).
Once the renal osteodystrophy has healed the action of the steroids
is unopposed and may be potentiated by the commonly associated mild
hyperparathyroidism. This might account for the findings of
Andresen and Nielsen (1982) of a low bone density in patients 67
months after renal transplantation; the mean value of bone mineral
concentration of the radius and ulna was 25% below age- and
sex-matched controls.
D. SUMMARY.
1. There was a reduction in mean Ca^ in 12 patients undergoing
renal transplantation.
2. The mean annual reduction in TBCa was -0.9% and the 95%
confidence limits were -3.2 to 1.4%. These changes were much
smaller than noted previously and may have been due to the lower
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dose of steroids used to prevent transplant rejection.
3. In the two patients who had parathyroidectomy for hypercalcaemia
the rises in TBCa were 3 and 8%.
4. There were large changes in plasma calcium, magnesium,
phosphate, alkaline phosphatase, and PTH following renal
transplantation. These changes were not related to the changes in
TBCa.
5. Hypercalcaenaia was a common finding after the operation and was
associated with detectable or raised plasma PTH. These levels of
plasma PTH were probably due to persisting impairment of renal
function.
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CHAPTER 8. PATIENTS AFTER PEPTIC ULCER SURGERY.
Aj_ OUTLINE OF STUDY.
This group of patients was larger than the
previous ones and they were more extensively investigated. An
attempt was made to demonstrate not only that bone mass was reduced
in these patients but also to try and identify the cause of this
reduction.
Ihe study was designed to determine the degree of osteopaenia
using TBCa measurements. Measurement of biochemical variables, in
particular plasma 25-OHD and PTH, were made along with tests of
calcium absorption and assessment of dietary calcium. The body
size, age, and social habits were taken into account. Finally, an
attempt was made to reverse the osteopaenia using vitamin D and
calcium therapy and measuring the response using forearm calcium
(FCa).
Many previous studies have been made on patients following
Polya partial gastrectomy as this was the most popular operation up
to the mid-1960's. In the present study the results of patients
having this type of operation are separated from those having the
more recently developed operations to determine whether the




The patients were selected from a register of
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patients who had undergone peptic ulcer surgery at the Western
General Hospital, Edinburgh. The path . h*"q"i<ad were one to 25
years postoperative. Between the years 1953 and 1 977 there were 990
operations for peptic ulcer of the type described in the
Introduction.
The results of the selection process are shown in Table 8a.
Only patients aged 50 to 70 years who lived in the Edinburgh postal
district were studied. Fran a list of these patients further
selection was as follows. Four male and four female patients frcm
each of three time intervals were selected using tables of randan
numbers. These three time intervals were one to five, six to 15,
and 16 to 25 years postoperative. This would have yielded 24
patients for each of the seven types of operation.
In order to increase the numbers of men after Polya partial
gastrectany a total of 80 were selected by random numbers. There
was no follow-up of clinic non-attenders.
2. Study options.
All patients underwent full clinical examination
lasting one hour. This was to assess the symptoms arising from the
peptic ulcer surgery, and fracture incidence, current therapy,
sunshine exposure, tobacco and alcohol consumption, occupation, and
to determine the presence of disease or the use of drugs likely to
affect calcium metabolism. The physical examination included the
measurement of height, weight, and skinfold thickness at four
sites.
Blood was taken without tourniquet in the non-fasting state
for alkaline phosphatase, phosphate, calcium, magnesium, albumin,
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25-OHD, PTH, lactate dehydrogenase, urea, and full blood count. A
"rine sample was tested with "Labstix" indbeat J pr far
glucose, protein, blood, and urobilinogen, and sent for analysis of
calcium and creatinine. At this time other investigations such as
chest radiographs were taken when appropriate.
The patients were seen between January and May of 1979 and
betweem January and May of 1980. Those patients seen in 1979 were
invited to join a study on the effect of vitamin D and calcium on
PCa. Patients were treated with placebo (lactose, one tablet twice
a day) or calcium and vitamin D (25mcg vitamin D^ and 20 mmol of
calcium daily). At each visit measurements were made of height,
weight, PCa, and the above biochemical measurements. Tablets were
returned at the end of the study so that they could be counted to
give an estimate of compliance.
Those patients seen in 1980 and those on placebo in the
treatment study were invited to have measurement of TBCa, 7-day
calcium retention, dietary calcium assessment, and urinary calcium,
magnesium, phosphate, hydroxyproline, and creatinine.
Ch RESULTS.
1« Patient selection and reasons for exclusion.
Table 8a summarizes
the number of patients remaining after each step in the selection
process. Fourteen patients were excluded from further study after
the clinical assessment. Six of these suffered from diseases likely
to affect calcium (primary hyperparathyroidism, 1, carcinoma of the
breast, bronchus and prostate, 5). Eight were taking vitamin D
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Table 8a. Selection of patients after peptic ulcer surgery.
Patients undergoing operations
listed in Table 8b
between 1953 and 1977
999 (73% male)
Patients now between the ages of 50 and 70 years







Patients suitable for study
132
Patients not taking vitamin D
124
V
Treatment study TBCa +
(FCa) urinary calcium
83 41









Number completing years' study
57
(24 vit D, 33 plac)
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supplements as multivitamin preparations (not prescribed for the
treatment of osteomalacia^ .jtuy U* body measurements of these
eight patients are included in the results.
Twenty-six of the patients who started the one year treatment
study left the study either because they left Edinburgh or because
they could not afford the time off work. Each visit took about one
hour. No patient left the study due to drug side-effects.
Two patients agreed to TBCa measurement but were not measured
due to lung calcification in one and ankylosing spondylitis in the
other. The bichemical results of these two patients are included in
the results.
The sex and operation type of the patients included in the
study are shown in Figure 8b.
2^ TBCa.
The mean and SD for TBCa in 41 men after peptic ulcer
surgery were 977g and 92g. This was 15% below the mean for male
TBCa controls and this reduction was highly significant (P<0.001).
Part of this reduction was due to the shorter stature of the men
after surgery. Their mean height was 1,70m and this was 8cm less
than the controls. Eight men were less than 1.64m tall (the lowest
value for the male controls) and so the formula for TBCa could not
P
be applied to these. In the remainder the mean Ca^^ was 0.94 (SD,
0.07) and this was a significant reduction (P<0.01). Six of the 33
patients had values of Ca^ below the reference range (i.e.18%). If
the patients after surgery were divided into those who had partial
gastrectomy and those who had other procedures both groups had
reduced mean Ca^ values of 0.95 and 0.94, respectively. Both
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Table 8b. Sex and operation type in patients after peptic ulcer
surgery,
Polya partial gastrectomy 36 6 42
Polya + vagotomy 12 0 12
Billroth I partial gastrectomy 10 6 16
Pyloroplasty + vagotomy 16 7 23
Gastroenterostomy + vagotomy 13 3 16
Gastroenterostomy 12 5 17
Highly selective vagotomy 5 1 6
Total 104 28 132
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results were statistically significant (P<0.05 and P<0.02,
respectively^ *
No other factors could be related to Ca^. There was no
significant effect of time since operation, biochemical
measurements, calcium absorption, body fat, or smoking or drinking
habits.
3. Biochemistry.
The results of plasma biochemistry are shown in
Table 8c. Patients were divided into three groups: men after Polya
partial gastrectomy and men after other operations, and wcmen after
all types of ulcer operation. Their results are compared with
controls for TBCa who were of similar age.
Multiple regression analysis was applied to each biochemical
variable so that the effects of sex and operation type could be
assessed. This analysis tested the effect of partial gastrectomy,
vagotomy, duodenal bypass, and acid reduction (see Introduction)
Plasma calcium was reduced in all men compared with controls
(P<0.001 ) but this was not found in the wcmen. Multiple regression
only showed up the significant effect of sex (P<0.05) with no
effect of operation procedure. Twenty-one percent of patients were
hypocalcaemic. After correction for albumin 11% of patients were
hypocalcaemic.
Plasma calcium showed positive correlations with plasma 25-OHD
(r=0.34, P<0.001 ) and with serum albumin (r=0.34, P<0.001). No
other biochemical variable was related to plasma calcium.
Plasma phosphate was not significantly different frcm
controls. Multiple regression analysis again showed an effect of
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sex. Wcmen had higher plasma phosphate than men (P<0.002).
Plasma magnesium was elevated compared witto ""'0.01).
The reference range of plasma alkaline phosphatase was
calculated from the results of the controls after logarithmic
transformation. The upper limit of normal was calculated as mean
plus 2 SD and was 77u/l. This was lower than the laboratory
reference value of 85u/l. Twenty patients had values above 77u/l
and this was 16% of the total.
Three SD above the mean for controls was 98u/l. Five patients
had values above this. Alkaline phosphatase electrophoresis
revealed the source as liver in three, intestine in one, and bone
in one. In the patient with elevated alkaline phosphatase of bone
origin the plasma 25-OHD was also low for the season at 7 nmol/1 in
April. However the plasma calcium, phosphate, and PTH were normal
in this case.
Of the five patients who had alkaline phosphatase values above
98 u/1 three took pert in the treatment study. Two received vitamin
D and calcium and the alkaline phosphatase fell from 108 to 83 u/1
in one and 105 to 74 u/1 in the other; the patient treated with
placebo also showed a fall in alkaline phosphatase frcm 122 to 102
u/1!
The results of plasma 25-OHD are shown related to
season-matched controls in Figure 8a. Nine out of 121 patients had
low values (i.e.7%). The details of plasma biochemistry in these
nine patients are shown in Table 8d. No patient had the classical
pattern of results for osteomalacia with low plasma calcium and
phosphate and high alkaline phosphatase and PTH.










Jan. Feb. Mar. Apr. May
1L
Figure 8a. Plasma 25-OHD in men and women (O) after peptic
ulcer surgery. The bars represent mean and 2SD after logarithmic
transformation of 25-OHD values in controls.
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controls in Figures 8b and 8c. The statistical analysis is made
difficult as some patients had value. V lower limit of
sensitivity of the PTH assay. The statistical methods are described
in detail in the Statistics Appendix and are referred to here as
the Fisher Exact Test and the Swan test. Using the Fisher Exact
test patients after peptic ulcer surgery had significantly elevated
FTH levels (men after Polya partial gastrectomy, P<0.02, men after
other ops, P<0.03, wcmen, P<0.001). The results of Swan analysis
are shown with the other biochemical results in Table 8c. The mean
PTH values are significantly higher in men and women after peptic
ulcer surgery, the mean PTH level being 60% higher than in
controls.
Plasma PTH rises as renal function declines to a creatinine
clearance of less than 50 to 80 ml/min (Lemann et al., 1979). This
40 to 66% reduction in renal function is equivalent to plasma urea
of 9 to 15 mmol/1 (Kassirer, 1971). Only four patients had urea
values above 9 mmol/1 and their PTH values were 0.22, 0.27, and
0.56 mcg/1 (one value missing). Exclusion of these results made no
differences to the results of the statistical analyses.
Eight of the urine collections were judged incomplete frcm the
urinary creatinine and lean body mass relationship described in
Chapter 3. In the remainder there were significant reductions in
urinary calcium, phosphate, hydroxyproline, and creatinine (Table
8e). These measurements were only nude in the male patients. As
discussed previously these men were shorter than the controls and
this would be expected to affect the urinary excretion of
creatinine and possibly of minerals. In order to allow for this 13










Figure 8b. Plasma PTH results in men after peptic ulcer surgery

















0L controls ulcer surgery
Figure 8c. Plasma PTH results in women after peptic ulcer surgery
compared with female TBCa controls.
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urinary calcium showed a
nnh the other urinary
4. 7-day calcium retention.
This was measured in 21 men and 2 wcmen.
The results are shown in Figure 8d. The reference range used in
this Figure was that of Mallette et al.(1975). Their control group
was 14 men of mean age 37 years who were taking a mean daily
calcium intake of 800 mg/day.
Sixteen of the 23 patients after peptic ulcer surgery had
results above the reference range. The mean 7-day retention was 50%
(10%, SD), compared with the mean for the control group of Mallette
et al.(1975) which was 38% (4%, SD). This difference was highly
significant (P<0.001). Patients with partial gastrectomy had
significantly higher values than those with other operations (mean
of 56% cf. 47% for other operations, P<0.02). These multiple
comparisons were made using analysis of variance.
The mean PTH was higher in the 16 patients with high 7-day
calcium retention than in those with normal values (Wilooxon rank
sum, P<0.05), as shown in Figure 8e. There was no significant
relationship between 7-day calcium retention and dietary calcium,
or plasma calcium, alkaline phosphatase, or 25-OHD.
Eight patients were restudied after four months treatment with
vitamin D and calcium. Change in 7-day calcium retention ranged
frcm -18% to +15% with a mean value of +1% (SD, 11%). The change in
7-day calcium retention was not related to initial plasma 25-OHD or
rise in 25-OHD. The mean rise over these four months in plasma
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Table8e.Resultsofurinebiochemi tryinmenft rp p iculcsurg rya dalecontrols forTBCa.Resultsarexpressedm an(SD)tatisticalcomparisonsdeu i g unpairedt-testfoheu m tchedgroupsandpairt-t tf matcgroups. Variable(units)ALLMEN UlceropC ntrolsHEIGHT-MATCHEDMEN UlceropC ntrols Number33 Calcium(mmol/24hr)3.7( .1 Magnesium(mmol/24hr)4.4(1.5) Creatinine(rnmol/24hr)12.7(3. Hydroxyproline(mcmol/24hr)26180)*** Phosphate(mmol/24hr)25(6)**17 5.8(2.8) 4.3(2.2) 17.3(3.8) 339(83) 34(11)13 3.1(1.3) 4.9(1.5) 13.3(3.2) 237(90) 26( )
**
13





















Figure 8d. Seven-day calcium retention in men X*1 an^ vromen (O)





















Figure 8e. Seven-day calcium retention in men _[E)_ and women (0)
after peptic ulcer surgery related to plasma PTH. Broken lines
represent the lower limit of detection of the PTH assay and the
reference range for 7-day calcium retention.
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25-OHD was 24nmol/l.
5. Dietary calcium and vitamin D.
The mean and SD of daily calcium
intake were 980g and 470g. This was based on the dietary assessment
of 25 patients.
The mean and SD of daily vitamin D intake was 5.3mcg and
4.2mcg. This was based on results of 13 of the above 25 patients.
Two patients were taking vitamin D supplements. When their data was
excluded the mean and SD of vitamin D intake were 3.9mcg and
2.5mcg. There was no significant relationship between vitamin D
intake and plasma 25-OHD.
6. Age and body measurements.
The results are shown in Table 8f
where they are compared to those of the TBCa controls. The mean age
of patients after peptic ulcer surgery was three to six years more
than in controls. As a result the warten were also more years
postmenopause than the female controls.
The men were shorter than controls. This affected the
interpretation of the results of TBCa and urinary biochemistry and
is discussed in those sections.
Both men and wcmen after peptic ulcer surgery were lighter
than controls. There was no significant fall in weight
postoperatively (95% confidence intervals, -1.4% to +1.1%). Weight
does not affect TBCa once allowance has been made for height and
body fat.
The three variables which related to body fat, namely, percent
- 130 -
body fat, body mass index, and percent overweight, were all
sigraiO rrdrced in patients after peptic ulcer surgery.
Multiple regression analysis was applied as described for
biochemistry to the estimates of body fat. There was no significant
effect of sex or operation procedure.
Lean body mass was lower in patients after peptic ulcer
surgery than in controls. This may have been due to their shorter
stature. To allow for this the data for lean body mass was
normalized in a similar manner to TBCa, to derive a predicted lean
body mass (LBM^).
LBMp = a x (height)X
where, a = 10.8 for wcmen,
a = 26.3 for men,
X = 2.76 for women,
X = 1.42 for men.
By dividing LBM by LBM^ a LBM ratio could be obtained. In the
controls this was 1.00 (0.10, SD) in men and 1.00 (0.07, SD) in
women. This was reduced to 0.91 in men after other peptic ulcer
operations (P<0.05) but the reduction was not significant in men
after Polya partial gastrectomy (mean, 0.95) or in wcmen (mean,
0.98).
7. Social history.
The results of alcohol consumption estimates are
shown in Table 8g. There was no relationship between alcohol
consumption and lactate dehydrogenase or mean corpuscular volume.
The figures are compared with the Scottish population as a whole in
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Table 8g. Alcohol consumption in patients after peptic ulcer







6 (6) 2 (7)
5 (6) 1 (4)
56 (53) 23 (85)
38 (36) 1 (4)
Ibble 8h. Cigarette consumption in patients after peptic ulcer






28 (27) 7 (26)
13 (12) 4 (15)
54 (51) 14 (52)
10 (10) 2 (7)
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the discussion.
, - tte consumption is shown in Table 8h. 72% of th<
74% of the wcmen smcked cigarettes. Again the results are compared
with the Scottish population as a whole in the discussion.
Social class distribution was similar to the population of
Britain with 11% in Class I, 19% in Class II, 11% in Class
III(non-manual), 37% in Class Ill(manual), 15% in Class IV, and 5%
in Class V. None were in class VI.
8. The changes in FCa and biochemistry following treatment with
vitamin D and calcium.
The initial characteristics of the two
treatment groups are shown in Table 8i. The treatment and placebo
groups were of similar age and years postoperative but the
treatment group had a greater preponderance of patients after
partial gastrectomy and of women. The results in initial
biochemistry were similar in the two groups.
The effects of treatment are shown in Table 8j. The plasma
25-OHD doubled following one years' treatment with vitamin D and
calcium. There were significant falls in plasma PTH (by 37%),
alkaline phosphatase (by 12%), and magnesium (by 5%). There were no
significant changes in FCa, plasma calcium or phosphate, or in
urinary calcium. There were no significant changes in the group
given placebo. Comparison between the treatment and placebo groups
showed a significant change in plasma 25-OHD only.
The seasonal variation in biochemistry in the patients treated
with placebo was calculated as in Chapter 3. The pattern of change
was similar, with a significant rise in plasma 25-OHD from 28 to 39
- 134 -
Table 8i. Details of treatment groups. Results are expressed as mean (SD),
Variable (units) Calcium and vit D Placebo All patients
Number 24 33 132
Age (yr) 59.0 (5.5) 62.3 (5.0) 60.1
Post-op (yr) 12.4 (6.2) 12.2 (7.2) 12.3
Sex ratio (M/F) 1.4 2.7 3.9
Op type (Polya/others) 0.85 1.20 0.69
Plasma
Alkaline phosphatase (u/1) 69 (18) 64 (22) 64
Phosphate (mmol/1) 1.04(0.19) 1.03(0.13) 1.02
Calcium (nmol/1) 2.33(0.09) 2.31(0.09) 2.31
Magnesium (mmol/1) 0.84(0.07) 0.84(0.05) 0.84
25-OHD (nmol/1) 26 (21) 27 (16) 25
PTH (mcg/1) 0.25(0.09) 0.25(0.10) 0.24
Urine
Calcium:creatinine 0.29(0.17) 0.38(0.21) 0.39
(mmol/l:mmol/1)
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Urine Calcium:creatinine (mmol/1:irmol/l) IVNAA Forearmcalciu(%)
0.10-0.05to0.25-0.02- .14t0.1 0.37-1.74to2.490.58-1.21t2.3
nmol/1 (P<0.01). Hie seasonal variation of plasma 25-OHD showed the
pattern (Figure 8f). The plasma calcium was ma
autumn, magnesium lowest in the summer, phosphate highest in the
summer, and alkaline phosphatase lowest in the summer, but none of
these changes reached statistical significance.
The mean and SD for compliance were 77% and 17%.
Dj_ DISCUSSION.
1. New findings in the present study.
The nature of metabolic bone
disease after peptic ulcer surgery has been studied by many
research groups. The discussion will be long as a result. In order
to highlight those findings which are new these will be summarized
first. This will be followed by a comparison with previous work and
this section will be organized in the same order as the results
section. Finally, an attempt will be made to interpret these
results.
The new findings are:
1. The demonstration of low bone mass in patients undergoing
operations for peptic ulcer surgery other than Polya partial
gastrectomy.
2. The failure of this reduction in bone mass to respond to
treatment with vitamin D and calcium.
3. The demonstration of normal plasma 25-OHD levels compared
with season-matched controls.
4. The demonstration of high plasma PTH levels after all
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Figure 8f. Plasma 25-OHD in patients after peptic ulcer surgery
treated with placebo for a year. The bars represent mean and 2SD
after logarithmic transformation of 25-OHD values in controls.
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5. The finding of high 7-day calcium retention after patients with
and without partial gasfcre ' . "— ^otic ulcer surgery.
A comparison is now made with previous work.
2.Bone mass.
Total body calcium values of 18 men after partial
gastrectomy were reported by Zanzi et al.(1977). Low values were
found in six of these men.
Larger groups of patients have been studied using photon
absorptiometry of the wrist. Blichert-Toft et al.(1979) found a
mean reduction on 7.3% and Aukee et al.(1975) a mean reduction of
7.4%. Both groups were studying men after partial gastrectomy.
These results were similar to the mean reduction of 5.3% found in
men after partial gastrectomy in the present studies.
Bone mass has been measured in patients after partial
gastrectomy by 5 different techniques based on radiographs of
bones. Metacarpal index was found to be reduced by Clark et
31.(1964), Deller and Begley (1963), Morgan et al.(1966), and Pryor
et al.(1971). Spine scores assessed by the method of Barnett and
Nordin (1960) were found to be reduced by Deller and Begley (1963)
and Eddy (1971), but not by Clark et al.(1964) or by Pryor et
al.(1971). The femoral neck as measured by the Singh Index was
found to be normal by Deller and Begley (1963). Radiogrammetry of
the bones of the hands and feet showed a reduction of the toes
(Arman et al., 1970) and of the hands of patients with high plasma
alkaline phosphatase or bone pains (Pridie et al., 1968). Fujita et
al.(1971) found reduced clavicular cortex thickness.
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No significant reduction in bone mass had previously been
—frated in studies of patients after operations of+-han
partial gastrectomy (Morgan et al., 1966, Blichert-Toft et al.,
1979, Irving et al.,1983).
Three factors have been shown to further reduce bone mass in
patients after partial gastrectomy. These were the interval since
operation (Alhava et al., 1974, Pryor et al., 1971), consumption of
alcohol (Nilsson and Westlin, 1972), and body fat (Pulvertaft,
1 968). None of these factors showed a significant effect on TBCa in
the present study.
3. Biochemistry.
Comparison between different studies is difficult
as the populations studied differ and the methods of biochemical
estimation vary. Thus the age, sex-ratio, and operation types might
be expected to alter the results as well as the conditions under
which the blood or urine were collected. The approach adopted here
is to study only cross-sectional studies of unselected cases and
compare the proportion of cases above or below the quoted
laboratory reference range. This method is not ideal as the
population on which the reference range is not usually described
and the ranges vary greatly from study to study. For example, the
lower limit of normal for calcium varies from 2.00 to 2.35 mmol/1.
Each biochemical variable will now be considered in turn.
There are 12 reports of plasma calcium which were based on a
total of 2887 patients after peptic ulcer surgery (Alhava et al.,
1974, Aukee and Jussila, 1972, Blichert-Toft et al., 1979, Deller
et al., 1964, Eddy, 1971, Jones et al., 1962, Morgan et al., 1965a,
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Pryor et al., 1971, Schofield et al., 1967, Tougaard et al., 1977,
Wastell, 1i9 ~!don et al., 1970). The proportion of
patients varied from 0 to 16%, compared with 21% in the present
study. The largest group of patients were the 1228 reported by
Morgan et al.(1965a). In this study 16% of patients after Polya
partial gastrectomy and 9% of patients after vagotomy and drainage
procedure were hypocalcaemic. After correction for specific gravity
these percentages were reduced to 5% and 4%, respectively. In the
present study plasma calcium was related to serum albumin and
correction for serum albumin reduced to proportion of patients who
were hypocalcaemic. Plasma calcium has not been shown to be
affected significantly by operation type or interval since
operation.
There are nine reports of plasma
phosphate which were based on 1214 patients after peptic ulcer
surgery (Alhava et al., 1974, Aukee and Jussila, 1972,
Blichert-Toft et al., 1979, Deller et al., 1963, Tougaard et al.,
1977, Wastell, 1969). In two of these studies there was a reduction
in plasma phosphate (Aukee and Jussila, 1972, and Eddy, 1971) and
in one study an increase (Alhava et al., 1974). In no study was the
sample taken in the fasting state. Plasma phosphate increases after
the menopause and so the higher values found in wcmen compared with
men in the present study were to be expected.
There have been two reports of plasma magnesium which were
based on 180 patients after peptic ulcer surgery. Blichert-Toft et
al.(1979) found normal mean plasma magnesium in 153 patients and
Tougaard et al.(1977) found a reduction in the mean plasma
magnesium in 27 patients. These results contrast with the present
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study in which an elevated plasma magnesium was found.
There have been 17 reper4"! rf plasma alkaline phosphatase
which are based on 3542 patients after peptic ulcer surgery (Alhava
et al., 1974, Aukee and Jussila, 1972, Blichert-Toft et al., 1979,
Clark, 1963, Deller et al., 1964, Eddy, 1971, Garrick et al., 1971,
Higgins and Pridie, 1966, Jones et al., 1962, Morgan et al., 1965a,
Pryor et al., 1971, Schofield et al., 1967, Thompson et al., 1966,
Tougaard et al., 1977, Wall et al., 1967, Wastell, 1969, and
Wheldon et al., 1970). High values were found in 13.2% of these
patients compared with 16% in the present study. The largest series
was that of Morgan et al.(1965a) who found elevated plasma alkaline
phosphatase levels in 6% of patients with peptic ulcer, 8% of
patients after vagotomy and drainage procedure, and 12% of patients
after partial gastrectomy. Only six of their 1228 patients had
osteomalacia. The commonest cause of high alkaline phosphatase in
their study was Paget's disease of bone. Treatment with vitamin D
for four months did not reduce plasma alkaline phosphatase in
patients who had high plasma alkaline phosphatase of undetermined
cause. Morgan et al.(1965a) found no effect of the time interval
since operation on plasma alkaline phosphatase. In a later study of
these patients Ambler et al.(1970) showed that increasing age,
blood group 0, and Polya partial gastrectomy were all associated
with high levels.
There have been four reports of plasma 25-OHD which have been
based on 62 patients after partial gastrectomy (Imiwari et al.,
1980, Lilianfeld-Toal et al., 1977, Schoen et al., 1978, and
Tougaard et al., 1977). Eleven out of 40 patients had low values.
These results were not compared with season-matched controls. In
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two of the studies over a third of patients were taking vitamin D
supplements and so the results of these patients included
in the above discussion. No relationship was found between plasma
25-OHD and time interval since operation (Shoen et al., 1978) or
with plasma calcium (Tougaard et al., 1977). In the present study a
positive correlation was found between plasma calcium and 25-OHD.
Such a relationship has not been demonstrated previously unless the
results of healthy and osteomalacic patients are combined (Stanbury
and Mawer, 1 978). This raises the possibility that in the present
group of patients there is a subgroup that is osteomalacic.
However, no individual fulfilled the criteria for the biochemical
diagnosis of osteomalacia with low plasma calcium and 25-OHD and
high plasma alkaline phosphatase and PTH.
There have been two reports of plasma PTH based on 42 patients
after Polya partial gastrectomy (Joffe et al., 1973, and Tougaard
et al., 1977). The assay used by Tougaard et al.(1977) was that of
Christensen (1976) which measured intact PTH and so the results
were lower than those in the present study in which mainly
N-terminal PTH was measured. The mean plasma PTH level in patients
after partial gastrectomy was 55% higher than controls (compared to
64% higher than controls in the present study). Joffe et al.(1973)
used the method of Schopman et al.(1970) which measures N-terminal
PTH and the mean level in 15 patients after partial gastrectomy was
0.29 mcg/1, a value similar to the mean of 0.27 mcg/1 found in the
present study. As their study included no controls they concluded
that PTH was normal after partial gastrectomy. An indirect method
of measuring plasma PTH levels is to measure urinary cyclic AMP.
Lilianfeld-Toal et al.(1977) found elevated levels of this after
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partial gastrectomy thus giving further support to the presence of
hyper . _ l~'~m in these patients.
There has been one report on urinary calcium based on patients
after partial gstrectomy (Clark et al., 1964). This showed urinary
calcium excretion of less than 2.5 mmol/24hr in 18% of patients
compared with 35% of patients in the present study. There have been
no previous study on unselected patients of urinary magnesium,
phosphate, or hydroxyproline.
4. Calcium absorption.
Measurements of calcium absorption are
affected by dietary calcium and by the amount of calcium carrier
given with the radioactive calcium. The amount of the label
absorbed may be estimated by whole body counting at 7 days (as in
the present study) or by measuring the radioactivity in blood,
urine, or faeces. A different isotope of calcium may be given
intravenously to allow for its disappearance rate from plasma. As a
result of these differences it is difficult to compare studies.
Two groups have found increased calcium absorption after
partial gastrectomy (Agnew and Holdsworth, 1971, and Arman and
Reizenstein, 1969), one group found normal absorption (Gregory and
van Uelft, 1972) and one group reduced absorption (Ikkos et al.,
1975).
Agnew and Holdsworth (1971) measured 7-day calcium retention
47of Ca given with 100mg calcium carrier as milk in 17 patients
after partial gastrectomy. Retention was higher than in controls.
Arman and Reizenstein (1969) measured 14-day calcium retention
47
of Ca given with 135mg calcium carrier as calcium chloride in
- 144 -
eight patient with the dumping syndrcme following Polya partial
gastrectomy. Refcer. vz^her than in controls and could be
reduced by giving the calcium carrier as milk (Arman et al., 1970)
or by treating the patients with oral calcium for two to six
months. A similar effect of milk on calcium absorption in patients
after partial gastrectomy was shown by Deller (1966).
Gregory and van Uelft (1972) measured radioactivity on blood
after giving radiocalcium orally with 20mg of calcium carrier in 25
men after partial gastrectomy. They found normal absorption.
Ikkos et al.(1975) measured urinary radioactivity after giving
two isotopes of calcium, one orally and one intravenously in 17
patients after partial gastrectomy. They found reduced calcium
absorption.
The present study is the only one to study patients after
operations for peptic ulcer other than partial gastrectomy. As it
is increased after these the mechanism is most likely to be related
to the reduction of acid secretion by the stomach. Acid solubilizes
dietary calcium as calcium chloride. Calcium will be poorly
solubilized in the absence of this acid and therefore not available
for absorption. In response to this there will be a fall in plasma
calcium, a rise in plasma PTH, and a rise in plasma calcitriol.
Thus when calcium is given in a solubilized form as calcium
chloride calcium it is hyperabsorbed. The reduction in calcium
absorption is more marked when the calcium is given with milk than
in patients who have not had peptic ulcer operations. Thus there is
a paradox in that calcium absorption appears high when tested with
solubilized calcium salts but is actually low when the calcium is
taken with food.
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5. Dietary calcium and vitamin
The mean daily intake of calcium
in the men in the present study was 1030 mg and this was similar to
that found by Pulvertaft (1968) in 37 men after partial gastrectomy
of 1090 mg, and by Agnew and Holdsworth (1971) in nine patients
after partial gastrectomy of 1100 mg. The mean dietary intake in
the U.K. is 1000 mg (Nordin, 1976) and the mean values of controls
in the studies of Pulvertaft (1968) and of Ekbcm and Hed (1965)
were 1340 and 880 mg. It is likely that calcium intake is normal in
patients after peptic ulcer surgery. The one group to whcm this
conclusion does not apply is those patients with lactose
intolerance causing weight loss and diarrhoea. Ekbcm and Hed (1965)
found that in this group the daily calcium intake was 650 mg.
Vitamin D intake was 4.3 meg/day in the present study and 3.9
meg/day in 37 men after partial gastrectomy reported by Pulvertaft
(1968). The controls in the latter study took 5.1 meg/day and in
the present study 2.6 meg/day. Thus vitamin D intake is normal
after peptic ulcer surgery.
6. Age and body measurements.
In the present study the patients
after peptic ulcer surgery were older, shorter, and lighter than
the controls. The mean age difference of four years was unlikely to
affect the results substantially.
The reasons for the increased height in the male controls are
given in Chapter 3. The height difference affected interpretation
of the results of TBCa, weight, and urinary minerals. Eight of the
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men were shorter than the shortest male control for TBCa. In
estimating the effect of height on lean body r~~~ - -Formula for
predicting lean body mass was used. In order to assess the effect
of height on urinary mineral excretion the patients were matched
for size.
The low weight was due to reduced body fat. Thus body mass
index, % overweight, and % body fat were all lower than in
controls. There was only a small reduction in lean body mass after
correction for height. The finding of reduced weight has been
thoroughly reported in patients after peptic ulcer surgery (Cox et
al., 1964, Golligher et al., 1968, Pryor et al., 1971, Wastell,
1969, and Wheldon et al., 1970). However, patients after peptic
ulcer patients are, on average, at their ideal weight and it is the
rest of the population who are, on average, 10% overweight! A
further point of interest is that there is no study which shows
that patients lose weight after the operation (Pryor et al., 1971,
and Wall et al., 1 967). The low weight may be partly related to
smoking. As shown in the present study patients after peptic ulcer
surgery smoke more than the general population. Indeed, smoking may
result in poor healing of peptic ulcers and hence necessitate
peptic ulcer surgery (Shearman and Finlayson, 1982). Smoking is
associated with a mean reduction in weight of 6 kg (Khosla and
Lowe, 1971).
7. Social history.
The Office of Population Censuses and Surveys
carried out a survey of drinking habits just five months before the
start of the present study (Wilson, 1980a). The survey reports on
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the alcohol consumption of 1134 men and women over the age of 20
years; In g:"^" to compare with the present study the survey'
groups are changed to abstainers, moderate drinkers, and heavy
drinkers (see Chapter 2 for definitions). The proportions of the
men in the survey in each group were 22%, 50%, and 28%,
respectively. In men after peptic ulcer surgery the proportions
were 11%, 53%, and 36%. This difference was significant using a
chi-squared analysis (P<0.05). The proportions of wcmen in the
survey in each group were 45%, 52%, and 3%. In wcmen after peptic
ulcer surgery the proportions were 11%, 85%, and 4%. This
difference was also significant (P<0.01).
The increased alcohol consumption may be underestimated by
this comparison as the figures given by Wilson (1980a) are for all
adults. By the age of 50 years mean alcohol consumption has fallen
by 25% compared with 20-year-olds.
Lee (1976) carried out a survey of the smoking habits of 4483
adults over 35 years in the United Kingdom. In order to allow
comparison with the present study the groups in the survey are
changed to non-smokers, light smokers (less than 10 cigarettes a
day), and heavy smokers (more than 10 cigarettes a day). In the men
of the survey the proportions in each group were 37%, 14%, and 49%,
respectively. In men after peptic ulcer surgery the proportions
were 28%, 12%, and 60%. This difference did not reach statistical
significance. In the wcmen of the survey the proportions were 61%,
14%, and 25%. In wcmen after peptic ulcer surgery the proportions
were 26%, 15%, and 59%. This difference was significant (P<0.001).
Consumption of cigarettes and alcohol slow ulcer healing and
so may make such patients more likely to require peptic ulcer
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surgery (Shearman and Finlayson, 1982).
Bone mass r ^ f^-^ed by smoking. Daniell (1976) showed
that smoking was associated with increased risk of vertebral
fracture and reduced bone mass (as measured by metacarpal cortical
area) in non-obese postmenopausal wcmen. Alcoholism reduces bone
density further in patients after partial gastrectomy (Nilsson and
Westlin, 1972).
Smoking may be the cause of the reduced body fat in these
patients (see above). It may also be the cause of premature death
of patients after peptic ulcer surgery. Ross et al.(1982) studied
the same patient population as in the present study and found as
excess mortality due to smoking-related diseases.
The social class distribution was similar to that of the UK
population in 1975.
8. Changes in bone mass and biochemistry following treatment with
vitamin D and calcium.
Alhava et al.(1975) studied the effect of vitamin D and
calcium on bone density and biochemistry. They studied 86 patients
who had undergone partial gastrectomy. Thirty-two were given no
treatment, 27 oral calcium (50 mmol/day), and 27 oral calcium and
vitamin D (25mcg/day). Thus the vitamin D dose was the same as in
the present study but the calcium was 2.5 times more. They measured
bone density by photon absorptiometry of the distal left radius for
a period of eight months. In the men there was a 5% increase on
calcium (P<0.05) and a 9% increase on calcium and vitamin D
(P<0.005). No significant change was shown in the 23 wcmen. There
was a fall in plasma alkaline phosphatase in the men treated with
- 149 -
vitamin D and a rise in urinary calcium to creatinine ratio in all
treated groups. Plasma calcium u-4-e did not change and
plasma 25-OHD and PTH were not measured.
The major criticism of the study of Alhava et al.(1975) is
that no information was given about the initial vitamin D status of
the population. The study was carried out on the Arctic Circle at
Kuopio in Finland. In a report of plasma 25-OHD at a similar
latitude in Norway, Vik et al.(1980) show that during the winter
normal plasma levels are maintained by vitamin D supplements.
In the study of Morgan et al.(1965a) fifteen patients with
alkaline phosphatase levels raised for reasons unknown were treated
with vitamin D. Five received placebo, five vitamin D 17.5
ncg/week, and five vitamin D 250 meg/week, intramuscularly. After
four months there was no fall in plasma alkaline phosphatase or
rise in calcium. This study took place in the U.K. and is further
evidence that this group of patients in this country are not
vitamin D-deficient.
In the placebo-treated group of the present study the plasma
25-OHD remained normal throughout the year. In those treated with
vitamin D the plasma 25-OHD levels doubled. This rise is smaller
than would be expected frcm the study of MacLennan and Hamilton
(1977). They treated 15 geriatric patients for four months with
12.5 meg vitamin D /day and found the plasma 25-OHD rise fran 22 to
53 nmol/1. This was half the dose used in the present study.
Although the compliance rate was estimated at 77% in the present
study the method of estimating compliance is cxrude. It is likely
that the compliance of the geriatric in-patients was better than in
the present study. An alternative explanation of this descrepency
- 150 -
would be that patients after peptic ulcer surgery malabsorb vitamin
. "bsorption of vitamin D was normal after parti ' my in
patients without steatorrhoea (Gertner et al., 1977, and Thompson
et al., 1966).
9. The cause of low TBCa after peptic ulcer surgery.
The most likely cause of osteopaenia after peptic ulcer
surgery is malabsorption of calcium and its associated secondary
hyperparathyroidism. The evidence may be summarized as follows:
a. Bone mass is reduced after all types of operation for peptic
ulcer.
b. The osteopaenia is associated with increased fracture
incidence.
c. Dietary intake of calcium in these patients is usually normal.
d. The absorption of solubilized calcium in these patients is
increased. However, when the calcium is given with milk it is
poorly absorbed.
e. Patients have hypocalcaemia, hypocalciuria, and secondary
hyperparathyroidism.
f. Plasma 25-OHD shows the normal seasonal fluctuation and is
normal.
g. Treatment with vitamin D and calcium reversed some of the
biochemical abnormalities but did not cause an increase in bone
mass.
h. The excess of osteoid that has been demonstrated in the bone
biopsies from these patients (Bordier et al.,1968, and Garrick et
al., 1971) could be due to secondary hyperparathyroidism rather
than osteomalacia.
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i. Low dietary calcium has been associated with an increased
fractur? :p«- ' . &/•: Yugoslavia (Matkovic et al., 1979). Metabolic
balance studies have shown that below a certain calcium intake the
calcium balance becomes negative (Gallagher and Riggs, 1978,
Whedon, 1981). After peptic ulcer surgery dietary calcium is less
available for absorption and so these patients may require a higher
dietary calcium intake than the general population to remain in
calcium balance.
Three other factors may contribute to the osteopaenia in these
patients. Smoking has been associated with reduced bone density and
increased fracture incidence in non-obese, postmenopausal wcmen
(Daniell, 1976). Alcoholism has been associated with reduced bone
mass in men after partial gastrectomy (Nilsson and Westlin, 1972).
Reduced body fat has been associated with reduced oestrone levels
in postmenopausal wcmen and with reduced bone density
(Christiansen, 1981).
Ej_ SUMMARY.
1. The mean reduction in Ca^ in men after peptic ulcer surgery was
5.3%. This reduction was associated with all types of operation.
2. After peptic ulcer surgery there was a reduction in plasma and
urinary calcium, an increase in plasma magnesium, alkaline
phosphatase, and PTH, and no difference from season-matched
controls in plasma phosphate and 25-OHD.
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3. There was an increase in 7-day calcium retention especially in
patients after partial < ,, T:righ retention results were
associated with high plasma PTH levels.
4. Dietary calcium and vitamin D were similar to controls.
5. Low body weight was due to reduced body fat. It was associated
with all types of operation and was no different from the
pre-operative weight.
6. Alcohol consumption was higher than the Scottish population as a
whole and smoking was more common in the women than in the U.K.
population.
7. Treatment with vitamin D and calcium for one year had no effect
on bone mass as assessed by FCa. The was an increase in plasma
25-OHD and falls in plasma PTH, alkaline phosphatase, and
magnesium.
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CHAPTER 9. CONCLUSIONS: THE VALUE OF TBCa MEASUREMENTS IN THE
INVESTIGATION OF METABOLIC BONE DISEASE,
The main advantage of TBCa over the other methods of assessing
bone mass is the low coefficient of variation of the normal range.
It is compared with other techniques in Table 9a. This allows easy
separation of normal frcm abnormal and in the present study
demonstrated reduced bone mass in patients with vertebral fracture,
primary hyperparathyroidism, osteomalacia, chronic renal failure on
haemodialysis, and after peptic ulcer surgery. In addition a
reduction in an individual of more than 15% is likely to be
detected by this technique.
The second advantage of TBCa measurements is the avoidance of
sampling error as the whole skeleton is assessed. Thus the changes
in TBCa after renal transplantation or after parathyroidectomy
represent long-term changes in calcium balance. This has the
limitation that if one bone is of interest, such as the radius in
women with wrist fracture, then one cannot make be certain that
changes in the whole skeleton are reflected in this bone. This was
also a problem in predicting vertebral fractures frcm TBCa
measurements as some types of metabolic bone disease affect
preferentially cortical or trabecular bone.
The third advantage of TBCa measurements is their good
reproducibility as this allows small changes to be measured.
However photon absorptiometry has a similar reproducibility and a
lower radiation dose and the apparatus for this technique is now
commercially available.
The demonstration of a fracture threshold in patients with
spontaneous vertebral fracture is one finding which may prove
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Table 9a. Methods for measuring bone mass in vivo. Only studies
snorting findings relevant to the present study and published in the
last ten years are included.













































useful in the future. If those wcmen at risk from such fractures
could be identified t_>_: - e loss might be prevented by
appropriate drug therapy. However, a prospective study of healthy
volunteers would be required before the method could be used in
this way.
The drawbacks of the method are several. Firstly, neutron
sources are generally expensive and not widely available. Secondly,
the dose of radiation is higher than other methods although well
within the safety limits for radiation workers. Thirdly the effects
of ectopic calcification is unknown.
Attempts have been made to predict TBCa from bone density
measurements using techniques such as photon absorptiometry which
have a lower radiation dose. Cohn et al.(1974) and Hesp et
al.(1982) find a close relationship between bone mineral content of
the distal radius and TBCa (r = 0.78, 0.77). Similarly, Hesp et
al.(1982) and Horsman et al.(1983) find a close relationship
between bone mineral content of the lower femur and TBCa (r = 0.76,
0.76, respectively). Horsman et al.(1983) used this relationship to
predict TBCa frcm lower femur bone density and the standard error
of the estimate was 80g. The authors felt this figure was
unacceptably high.
The relationship of bone density and TBCa was close because
both measurements are dependent on body size. Indeed, the
2 07
relationship between (height) * and TBCa in the men of the
present study was even closer (r =0.83)! Cohn et al.(1974)
normalized TBCa for body size (Ca^) and bone mineral content of the
radius for radius width and the correlation coefficient was only
0.45. At present there is no substitute for measuring TBCa.
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APPENDIX; STATISTICAL METHODS.
Three stastistical methods were used which need further
explanation.
1. Regression analysis applied to logarithmically-transformed data.
This technique was applied to TBCa measurements and body size and
to lean body mass and its relationship to height.
If, YocX11
Then, loge (Y) = n x loge (X)
Regression of log (Y) on log (X) gives n as the0 0
regression coefficient.
In the example of TBCa, Y is TBCa and X can be age, years
postmenopause, height, span, or lean body mass.
In men,
Variable Regression coefficientCorrelation coefficient P
Age -0.38 -0.54 <0.02
Height 2.07 0.84 <0.001
Armspan 1.80 0.74 <0.001
Weight 0.21 0.54 N.S.
Lean body mass 0.54 0.54 <0.02
Age -0.89 -0.66 <0.005
Height 2.18 0.56 <0.02
Armspan 2.24 0.63 <0.005
Weight 0.36 0.42 N.S.
Lean body mass 0.57 0.48 <0.05
- 157 -
Multiple regression may be applied if TBCa were likely to be
dependent on several variables. In postmenopausal women it would oe
expected that age and body size would affect TBCa independently.
The closest relationship (as judged by the coefficient of
correlation) was between TBCa and armspan and years postmenopause.
The following equations were used to derive this relationship.
TBCa sn x eX x yf"
after logarithmic transformation to base e,
loge (TBCa) C + n x loge (s) + X x ypm
apply multiple regression equation to the data frcm the female
controls:
loge (TBCa) = 5.99 + 1.69 x loge (s) - 0.015 x ypm
i.e. TBCa = 399 x s1"69 x e"0'015 x ^
with r = 0.89, and P<0.001.
When lean body mass was included in the analysis r was not
increased.
2. Analysis of the PTH results.
This was difficult as some
results were below the lower limit of sensitivity of the assay. Two
approaches were used.
a. Fisher's Exact Test.
The total number of patients was halved and




TTTCER OPS CONTROLS TOTALS
HIGH 51 4 55
LOW 41 15 56
TOTALS 92 19 111
In the wanen,
ULCER OPS CONTROLS TOTALS
HIGH 17 4 21
LOW 5 16 21
TOTALS 22 20 42
Applying tables for Fisher's Exact Test the significance values for
men and women were P<0.01 and P<0.001.
b. Swan analysis.
This analysis is named after the statistician who
described it and the program is available on the Digital Equipment
Corporation computer at the Clinical Research Centre, Watford Road,
Harrow. The analysis assumes that the data is normally distributed
and predicts the value of the censored data frun the known data.
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Abstract. An irradiation system has been designed, using a neutron beam from a cyclotron,
which optimises the uniformity of activation of calcium. Induced activity is measured in
a scanning, shadow-shield whole-body counter. Calibration has been effected and repro¬
ducibility assessed with three different types of phantom. Corrections were derived for
variations in body height, depth and fat thickness. The coefficient of variation for repeated
measurements of an anthropomorphic phantom was 1.8% for an absorbed dose equivalent
of 13 mSv (1.3 rem). Measurements of total body calcium in 40 normal adults were used
to derive normalisation factors which predict the normal calcium in a subject of given size
and age. The coefficient of variation of normalised calcium was 6.2% in men and 6.6%
in women, with the demonstration of an annual loss of 1.5% after the menopause. The
narrow range should make single measurements useful for diagnostic purposes.
1. Introduction
Total body neutron activation analysis is now established as one of the most important
methods of determining the elemental composition of the human body. It can be
used to determine both the absolute amount and changes with time of certain body
elements, in particular calcium, sodium, chlorine, phosphorus and nitrogen (Cohn
1981).
In the technique, the subjects are exposed to a beam of partially moderated fast
neutrons which induces amongst others the reactions 48Ca(n, y)49Ca, yNa(n, y)24Na,
37Cl(n, y)38Cl, 31P(n, a)28Al and 14N(n, 2n)13N. The radioactive isotopes produced
then decay, emitting y-rays which can be readily detected in a whole-body counter.
If the reproducibility of the method were good then small changes in the body
elements with time might be detected relatively easily. Absolute quantification of the
elements is more difficult, because of the natural variation in body dimensions and
the difficulty of obtaining a suitable variable phantom of known composition for
calibration. To overcome these problems several different approaches have been
made. Nelp et al (1972) made repeated measurements on five cadavers of different
sizes and then ashed the skeletons to determine the calcium content. Cohn and
Dombrowski (1971) and Cohn etal (1972) used only one size of phantom for activation
and depended on the invariant response of a 54-detector whole-body counter (Cohn
et al 1969). Three sizes of phantom were used by Williams et al (1978); their patients
0031-9155/82/050697 + 11 $1.50 © 1982 The Institute of Physics 697
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were then graded into three groups according to body habitus. Two different sizes
of phantom were used by Spinks et al (1977) and the effects of varying thickness or
adding wax around these phantoms were studied by Spinks (1979). The effect of
varying the thickness of the trunk and thighs was also studied by McNeill et al (1974).
Oxby and Brooks (1979) have tackled the problem of varying body dimensions by
designing a complex phantom of variable shape and content.
This paper describes the technique used in Edinburgh to measure total body
calcium (raCa) with a high degree of precision and also our methods of overcoming
the problems mentioned above. The technique of evaluating whether a subject
contains a normal amount of calcium is in two parts. Firstly, corrections to eliminate
the effects of variations in activation and detection efficiency due to varying body
dimensions are made. This enables the absolute amount of calcium in the subject in
grams to be evaluated and requires a variety of phantom measurements. Secondly,
the normal predicted total body calcium is calculated using a formula derived from
the results of a group of healthy normal volunteers aged 40-70 years. These results
were used to obtain a range of normal values of the body elements of interest.
Total body calcium measurements of normal volunteers have also been made by
Nelp et al (1972), Cohn et al (1976), Aloia et al (1978), and Chesnut et al (1981).
Where appropriate, the results of these studies and the data presented in this paper
will be compared and discussed.
2. Method
2.1. Neutron activation
The neutron source used for patient activation was a cyclotron producing neutrons
of mean energy 6.5 MeV by the reaction of 15 MeV deuterons on a beryllium target
(Williams et al 1979). During irradiation the subject was positioned in a moderator
kiosk made from 3 cm thick polyethylene sheets mounted on a turntable. The thickness
of the premoderator was chosen, after preliminary measurements, in order to minimise
the variation in the thermal neutron flux through the patient. This was measured
using a 235U fission chamber with and without a cadmium shield; in a phantom 24 cm
Figure 1. The thermal neutron flux profile through awater tank of depth 30 cm; A, with unilateral irradiation;
B, with bilateral irradiation. Using the first and last 3 cm (shaded areas) as premoderator, the profile
through a subject 24 cm deep may be observed.
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Figure 2. The irradiation enclosure. The rear wall is brought forward until the subject's trunk is in contact
with both the front and rear walls. The depth of the perspex window was chosen so that the effect on the
thermal neutron profile was equal to that of the 3 cm thick polyethylene walls.
deep this variation was ±7% (figure 1) and in a limb phantom 12.5 cm in diameter
the variation was ±13%. The back wall of the kiosk was movable and was adjusted
so that the subject's trunk was in contact with both the front and back walls (figure
2). This contact kept the subject in the correct position and gave extra support. The
fixed neutron dose was given to the patient in two successive irradiations each lasting
about 22 s, with the kiosk rotating through 180° in 18 s after the first irradiation and
before the second. These times were checked with a stopwatch and a decay correction
applied if necessary. The target to subject distance was 5.4 m.
Using a Geiger-Miiller tube sheathed in 3 mm of 6LiF, the photon absorbed dose
was measured as 0.4 mGy. The total dose, measured at the position of the pelvis
using a tissue-equivalent ionisation chamber, was 1.68 mGy, and was nearly constant
with depth through the patient. Using a neutron quality factor of 10 therefore, the
total dose equivalent received by the patient was 13.2 mSv. This dose was controlled
by the neutron monitor chamber of the beam and the irradiation calibrated by
activating simultaneously a container of Na2C03 in a polyethylene jacket mounted
on the side of the moderator kiosk. Possible long term variations in the neutron beam
distribution were monitored by weekly measurements of the Bush phantom.
2.2. Measurement of induced activity
After irradiation, the patient was transferred to a shadow-shield whole-body counter
containing four 15 cm diameter x 10 cm thick sodium iodide detectors, two above and
two below the bed, arranged in line across the patient. The separation of the upper
and lower counters was 40 cm. Four 200 cm scans at constant speed, each lasting five
minutes, were then performed. The scan direction was simply reversed at the end of
each scan. The time from the end of the irradiation to the start of the first scan was
measured and was usually about 6 min.
700 N S J Kennedy et al
The patient spectrum, covering the energy range 0-4 MeV, was recorded on a
multichannel analyser. A twenty minute background count, measured using an inactive
phantom, was then subtracted from the patient spectrum and the difference was
punched out on paper tape for computer analysis.
2.3. Spectral analysis
The data were analysed by fitting five standard spectra, those of calcium, sodium,
chlorine, phosphorus and potassium to the smoothed subject spectrum in the energy
range 1.0-3.4 MeV, using a least squares technique (Smith et al 1976, Smith and
Tothill 1979). The standard spectra were obtained by separately filling a phantom of
human dimensions with appropriate solutions, activating the phantom and then record¬
ing the spectra on the whole-body counter. When the best possible fit to the subject's
spectrum had been obtained, the amount of each standard required to make up the
spectrum was listed. These amounts were then divided by the count from a twenty
minute scan of the Na2C03 standard. The values for each element were then corrected
for radioactive decay.
In addition to the major elements of interest, some nuclides are activated which
interfere with the measurement of the elements under analysis. The main interfering
reaction in the measurement of calcium is the ,7Cl(n, p)37S reaction, since the "S
produced has a 5.06 min half-life and a gamma-ray energy of 3.1 MeV. The correction
applied to the calcium content, obtained by activating chlorine in a water-filled
phantom was 3.1% of the chlorine count corrected back to the reference time. By
similar methods, the reaction ,9K(n, 2n)38Km was found to contribute 0.9% of the
total counts in the chlorine region (2.00 to 2.32 MeV) and the 24Mg (n, p) 24Na reaction
contributed 0.8% of the total counts measured in the sodium region (2.57 to 2.92 MeV)
when the composition of reference man (IRCP 1975), was assumed. The interferences
from the last two reactions were regarded as negligible.
3. Results
3.1. Reproducibility
The reproducibilities of the measurements of calcium, sodium, chlorine and phos¬
phorus were investigated by repeatedly measuring a phantom which consisted of
hollow polyethylene sections containing known amounts of the elements of interest
(Bush 1946). The water-filled weight of the phantom was 68.5 kg and its height
172 cm. Three separate filling mixtures were used (see table 1) and these mixtures
were irradiated 3, 3 and 7 times respectively. In the final mixture, the total amounts
Table 1. Contents of phantoms (in g).
Phantom composition Reference man
Element 1 2 3 (IRCP 23)
Calcium 600 802 1009 1000
Sodium 60 70 84 100
Chlorine 50 61 70 95
Phosphorus 455 455 455 780
Potassium 120 120 130 140
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of the various elements were similar to those in reference man (IRCP 1975) with the
exception of phosphorus where more recent results imply that the quoted content is
too high. There was no significant dependence of the counts obtained per gram of
element on the ratio of the various elements in the phantom. The reproducibilities
(coefficients of variation (cv)) of the measurements of the various elements, obtained
from the 13 irradiations of the phantom, using the same dose as given to the patient,
were ±1.7% for calcium, ±2.2% for sodium, ±4.3% for chlorine and ±4.3% for
phosphorus. The values of the cv for calcium, sodium and chlorine reflect almost
entirely the counting statistics for these elements. For a small female with only 500 g
of calcium the cv for calcium would increase to about 3.0%. The reproducibility of
the measurement of calcium was also investigated by repeatedly measuring a phantom
consisting of a human skeleton with approximately 700 g calcium encapsulated in
tissue-equivalent rubber. The reproducibility in this case, determined from 10
measurements, was 1.8% for calcium and 2.1% for sodium.
3.2. Measurement corrections
In this section the corrections required to allow for the influence of body habitus on
the combined activation and counting efficiency are determined. These corrections
are essential for accurately calculating the absolute amount of calcium in the subject.
3.2.1. Effect of height. The thermal neutron fiuence at a depth of 5 cm, over an area
185 cm high and 60 cm wide at the subject irradiation position, was uniform to within
±8% with the maximum incident neutron flux around 85 cm above the chamber floor.
The effect of varying height was tested by altering the height of the water filled
phantom over the range 150 cm to 193 cm by inserting wax spacers between the
various sections. The phantom was measured twice at each of five different positions.
The range 150 cm to 172 cm was investigated by removing the pelvis section. The
results obtained were fitted by the power law:
% loss of counts = 0.5 (subject height—1.5)2 x 100 height>1.5m.
3.2.2. Effect of body build and body fat. The effect of variations in thickness of the
subject, measured along the beam direction, was investigated using sections of the
solution-filled phantoms of different sizes, but similar heights. Two repeated measure¬
ments were made at each of five different thicknesses i.e. 11, 14, 16, 18 and 24 cm.
The decrease in measurement efficiency was 1.8% per cm increase in thickness of
the chest section and 1.4% per cm increase in diameter of the limb section.
3.2.3. Effect of wall separation. Ideally the front and back premoderator sections of
the activation chamber are positioned just to touch the subject's trunk at the front
and back. The separation of the walls is dependent, therefore, on the subject's depth
measured along the beam direction (figure 2). Due to patient apprehension in some
cases this is not possible and the walls are positioned further back than normal. The
effect of this extra separation was investigated by repeatedly measuring both the
solution-filled and the skeletal phantoms, increasing the wall separation each time up
to an air gap of 10 cm. Two repeated measurements were made at each of three
different positions. The decrease in activation efficiency was 1.0% per cm increase
in the air gap.
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3.2.4. Absolute calibration of calcium. Using the results from sections 3.2.1 to 3.2.3,
the mass of calcium in the subject in grams was calculated from the equation:
TEsCa = measured calcium x height correction x depth correction
xfat correction x wall correction
where
height correction = 0.5 (subject height—1.50)2+ 1 height > 1.5 m
= 1 heights 1.5 m
depth correction = 1.6 (Subject depth—tst—0.2) +1
/tst + LST\
fat correction = 3.6 ^ J +1
wall correction =1.0 (wall separation — subject depth) +1.
All measurements are in metres and tst = mean torso skinfold thickness of subject,
i.e. the mean of the subscapula and iliac crest measurements; lst = mean limb skinfold
thickness of subject, i.e. the mean of the biceps and triceps measurement; 1.6 = mean
fractional loss per m increase in depth; 3.6 = mean fractional loss per m increase in
fat; 0.2 = reference depth, i.e. the depth of the trunk section of the solution filled
phantom. The depth correction makes the assumption that the depths of the various
limbs scale in proportion to the depth of the trunk.
The number of counts obtained per gram of element was checked by repeatedly
activating three phantoms of different sizes similar to the Bush phantom but with the
calcium and phosphorus contained in solid rods which simulated the human skeleton
(Battye et al 1971). The results obtained for sodium and chlorine agreed within
experimental error. However the calcium was on average 3.1% low and the phos¬
phorus result 11.2% low compared with elements dispersed in solution. This effect
might well be explained by the difference in the combined efficiency of activating and
detecting the calcium and phosphorus when they are uniformly distributed in the
phantom compared with when they are contained in a simulated skeleton. This effect
has also been noted by Spinks et al (1977). The necessary change was therefore made
to the conversion factor for calcium to give counts per gram of the element. The
difference between the results of calcium and phosphorus was due to the fact that the
latter undergoes a fast neutron reaction.
4. Normalisation procedures
To establish the range of normal values for total body calcium, 40 normal volunteers
were measured: twenty males (six aged 40-49, eight aged 50-59 and six aged 60-69)
and twenty females (two aged 40-49, ten aged 50-59 and eight aged 60-69). All the
subjects were active and in good health. None had any history of disease that might
be expected to influence calcium metabolism, and all had normal blood and urine
biochemistry. There was a large variation in the total body calcium results for both
groups (table 2). The females ranged from 596 to 1036 g with a mean of 821 ± 15.2%
(cv), while the males ranged from 886 to 1428 g with a mean of 1143± 11.7%. Since
the total body composition of the various elements is clearly related to the subject's
build, a mean value based on sex alone is inadequate. Therefore the dependence of
the measured TBCa on height, span, weight, lean body mass (calculated from the
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Table 2. Data for normal controls.
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Means and percent coefficients of vari¬
ation
Male (cv) Female (cv)
Number 20 20
Height (m) 1.770(4.7) 1.622 (4.2)
Span (m) 1.843 (4.7) 1.655 (4.4)
Weight (kg) 81.8(13.8) 63.7(17.2)
Calcium (g) 1143(11.7) 821 (15.1)
skinfold thickness measurement), age and number of years post-menopause was
investigated by multiple linear regression analysis.
For males, this gave a formula for predicted total body calcium in grams (TBCap),
TBCap = 347 (height)2 07 (r = 0.84, P< 0.001).
Total body calcium was also found to be strongly dependent on span
TBCap = 384 (span)180 (r = 0.74, P< 0.001).
Height and span are measured in metres. Perhaps because the spread in age was
small no significant dependence of total body calcium on age was observed. Weight
and lean body mass also proved to be unimportant. The biological variation in normal
TBCa due to size could be reduced by expressing the subjects result in terms of the
ratio TBCa/TBCap. When height was used in the formula the cv in the male controls
was reduced to 6.2%.
For the female controls, multiple regression gave
TBCap = 399 (span)1'69 exp(-0.015 Y) (r = 0.90, P< 0.001)
where span was measured in metres and Y is the subject's years post-menopause.
This gave a highly significant correlation with an annual loss of calcium after the
Years post-menopause
Figure 3. Total body calcium of normal women, normalised using the span (s), plotted against years
post-menopause. The line representing a loss of 1.5% per annum is plotted with confidence and tolerance
limits, a is a constant = 399; •, normal women; , confidence limits, P = 0.05; , tolerance limits,
P = 0.10.
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menopause of 1.5% (figure 3). An equally good correlation was obtained if a linear
relationship between calcium and years post-menopause was assumed. Total body
calcium, for the female controls, was also found to be strongly dependent on height
TBCap = 443 (height)1'57 exp(0.016 Y) (r = 0.87, P < 0.001).
Since total body calcium was more strongly correlated with span than with height
and as height may be significantly reduced in patients with osteoporosis, it was decided
to use span rather than height as a variable for normalisation for women. The
coefficient of variation of total body calcium in normal women TBCa/TBCap, after
normalisation improved to 6.6%.
The possibility was investigated that the correction factors, applied to the raw
data, described in section 3.2.4 could be replaced with an extra normalisation factor,
namely weight. Regression analysis performed on the uncorrected data for the male
controls gave a low correlation with height, r = 0.40, compared to the corrected data,
r = 0.84. The introduction of weight as a normalisation factor improved the correlation
considerably
TBCap = CM (height)215 (weight)-0'34 (r = 0.80)
where the superscript indicates that this equation refers to the raw data, uncorrected
for the height, build and body fat corrections derived in section 3.2.4.
A similar effect was obtained, using the uncorrected female data, after the introduc¬
tion of a normalisation factor for weight
TBCa1 = CF (span)1'66 (weight)-0'18 exp(-0.016 Y) (r = 0.89)
where CM and CF are constants.
This contrasts with the case of the corrected data, both male and female, where
weight proved to be unimportant. Therefore to a large extent the correction factors
described in section 3.2.4 and the introduction of weight as a normalisation factor
fulfil a similar function. The cv of the TBCa'/TBCp ratio was 7.0% for both men
and women. When the ratio is used, the units of TBCap can be left as 49Ca counts.
However, using the results from the calculations of TBCap, the values CM= 1447 and
CF = 870 will give TBCap in grams of calcium.
5. Discussion
The technique of total body neutron activation analysis presented in this paper with
its precision of 1.8% on phantoms is suitable for detecting small changes in total body
calcium. The process of correcting for varying body dimensions is most important for
the accurate determination of the absolute amount of calcium in the body. When the
corrections described in section 3.2.4 were applied to the raw data for our normal
male volunteers they increased the estimated body calcium by 16% on average. The
importance of such corrections has also been emphasised by Spinks (1979). Using a
similar irradiation system, he found correction factors for total thickness and wax
layer thickness which were close to ours. McNeill et al (1974) also studied the effect
of body thickness on the efficiency of activation and measurements of calcium in the
trunk. They found a reduction of calcium counts of 5% cm-1. Their figure was
somewhat higher than ours, probably because their Pu-Be sources were a fixed distance
apart and fairly close to the subject's skin. Correction for body stature is important
not only for absolute calcium determinations, but also for studying changes over a
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period if the subject is likely to alter in weight. Some treatments which lead to
osteodystrophy, or which are designed to avoid the condition, are liable in themselves
to change the amount of fat in the body.
The establishment of a normal range of total body calcium for men and women
is vital if full use is to be made of the absolute values. Total body calcium measurements
of normal volunteers have been made by Nelp et al (1972), Cohn et al (1976), Aloia
et al (1978) and Chesnut et al (1981). Partial body (trunk) measurements have been
made by Harrison et al (1975) and by McNeill and Harrison (1977). The most
comprehensive of these studies is that of Cohn et al (1976). They derived equations
for predicting normal values based on measurements on 79 normal individuals, 48 in
the age range covered by this study. Their whole body counter corrects for variations
in response due to different body dimensions, but no attempt was made to separate
variations in activation efficiency from the biological variations of actual calcium
content in the normal population studied.
The equations developed by Cohn et al (1976), which incorporate height, age and
total body potassium levels, therefore included a consideration of measurement errors,
as well as statistical variations. The coefficient of variation of normalised total body
calcium was 7.8% for men and 7.1% for women. As a result of the different approach
to normalisation and because Cohn et al (1976) assumed a uniform age of menopause
at 55, our values of total body calcium are not directly comparable with theirs. As
in this study, Cohn et al (1976) found total body calcium in males to be dependent
approximately on height squared. These results are in slight disagreement with the
total body calcium study of Nelp et al (1972) and the partial body studies (trunk) of
Harrison etal (1975) who found a near cubic relationship between calcium and height.
The percentage of calcium lost by normal women after the menopause of 1.5%
per year from this study is slightly higher than that of 1.1% determined by Cohn et
al (1976). They also calculated a rate of calcium loss of 0.4% per annum between
the ages of 35 and 55. This is probably the combination of a lower (if existent)
pre-menopausal bone loss and a higher post-menopausal loss from those normal
women who were post-menopausal before the age of 55.
Although multiple regression analysis on our male data gave a mean loss of calcium
with age of 0.1% per year, this result was not significantly non-zero. Cohn et al
(1976) reported a mean annual loss of calcium for the average man of 0.70% after
50 years of age. However it is interesting to note that their result, whch was obtained
by omitting their data for men over 80, leads to such a low predicted value of calcium
for older men that the majority of their own male subjects aged 67 and over have
TBCa/TBCap values substantially greatei than one.
In section 4 it was shown that the introduction of weight as a normalisation factor
applied to the raw data, rather than using the correction factors described in section
3.2.4, implied that total body calcium was dependent partly on (weight)-0'34 for males
and (weight)-0 18 for females. These values are in broad agreement with the exponent
determined by Cohn etal (1976) of -0.25 (see appendix Cohn etal 1976, substituting
Kp for K). We obtained no significant dependence on weight after multiple regression
analysis was performed on the final data because of the correction factors used in
section 3.2.4. For the determination of a narrow normal range of calcium values the
use of weight as an extra normalisation factor would appear to be almost as good,
and would be simpler than determining and applying the various correction factors
for height, body fat and thickness. The success of weight as a normalisation factor
presumably depends on its close correlation with body thickness. However the body
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correction factors described in section 3.2.4 are important for the accurate determina¬
tion of the absolute amount of calcium in grams in individuals whose size or shape
differs, even by only a few centimetres, from the phantom used for calibration. The
values of the correction factors are only applicable to the experimental arrangement
used in this study. However if other research groups were able to calculate accurately
the absolute amount of calcium in grams in their patients then the equations for
TBCap derived from our normal controls could be used to calculate the TBCa/TBCap
ratio.
We believe that the best approach is the one we have adopted, of first trying to
establish an accurate measure of whole body calcium, making correction for all the
variables likely to affect activation and detection efficiency, and then deriving normali¬
sation factors which take into account variations of calcium with size, age and sex.
The narrow ranges for normal subjects that we have observed, with coefficients of
variation of 6.2% for men and 6.6% for women, may allow the technique of total
body neutron activation analysis of calcium to be a useful diagnostic procedure.
Acknowledgments
We wish to express our gratitude to the staff of the MRC Cyclotron Unit at Edinburgh,
in particular Mr T Saxton and Mr J Williams, for their considerable cooperation and
assistance, Mr L Mackie and Mr H Easton for skillful workshop services and Mrs
Elisabeth Law for technical assistance. We should also like to thank Mr T J Spinks
and Professor K Boddy for allowing us to use their phantoms.
This work was supported by grants from the Scottish Home and Health Department
and from the Medical Research Council.
Resume
Analyse par activation neutronique du calcium de corps entier: calibration et normalisation.
Nous avons realise un systeme d'irradiation, utilisant un faisceau de neutrons emis par un cyclotron, qui
optimise l'uniformite de l'activation du calcium. L'activite induite est mesuree par un compteur corps
entier a balayage 'shadow shield'. Nous avons calibre les mesures et teste leur reproductibilite a partir de
trois types differents de fantomes. Nous en avons deduit des corrections pour les variations de la taille du
corps, de la profondeur et de l'epaisseur de la graisse. Le coefficient de variation pour les mesures repetees
sur un fantome anthropomorphe est de 1,8% pour une dose absorbee equivalente a 13 mSv (1,3 rem).
Nous avons utilise les mesures du calcium global du corps chez 40 adultes normaux pour deduire les
facteurs de normalisation qui predisent le taux normal du calcium chez un sujet d'age et de taille donnes.
Le coefficient de variation du calcium normalise est de 6,2% chez 1'homme et de 6,6% chez la femme
avec une perte annuelle de 1,5% apres la menopause. Cette faible dispersion des valeurs rendrait utile
une seule mesure a des fins diagnostiques.
Zusammenfassung
Ganzkorper-Neutronenaktivierungsanalyse von Kalzium: Kalibrierung und Normierung.
Mit Hilfe eines Neutronenstrahls aus einem Zyklotron wurde ein Bestrahlungssystem konstruiert zur
Optimierung der Gleichformigkeit der Kalziumaktivierung. Die induzierte Aktivitat wurde in einem
Ganzkorperzahler mit Schattenschutz gemessen. Eine Kalibrierung wurde durchgefiihrt. Die Reproduzier-
barkeit wurde mit drei verschiedenen Phantomtypen bestimmt. Korrekturen fur Anderungen der Korper-
hohe, -tiefe und -dicke wurden abgeleitet. Der Variationskoeffizient fiir Wiederholungs-Messungen an
einem anthropomorphen Phantom betrug 1.8% fur eine Aquivalentdosis von 13 mSv (1.3 rem). Messungen
des Ganzkorper-Kalziums bei 40 gesunden Erwachsenen wurden benutzt um Normierungsfaktoren
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abzuleiten, die den normalen Kalziumgehalt eines Menschen bei vorgegebener Grofle und Alter vorher-
sagen konnen. Der Variationskoeffizient von normiertem Kalzium var 6.2% bei Mannern und 6.6% bei
Frauen, mit einem jahrlichen Verlust von 1.5% nach der Menopause. Der eingeschrankte Bereich konnte
einzelne Messungen fiir diagnostische Zwecke brauchbar machen.
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Abstract
Total body calcium (TBCa) was measured using a cyclotron
for in vivo neutron activation analysis (IVNAA) in 20 healthy
women, 15 women with vertebral compression fractures,
and 8 women with wrist fractures. The precision of the tech¬
nique, using phantoms, was 1.8% for a dose of 13 mSv. A
formula for predicted TBCa (TBCap) was derived from the 20
normal women based on span and years postmenopause.
The coefficient of variation of TBCa after normalization in
the normal women was 6.6%. The mean TBCa values for the
vertebral and wrist fracture groups were 69% and 84% of
TBCap for women at the time of the menopause. The low
TBCa in the wrist fracture group was attributable to post¬
menopausal bone loss. Of the low TBCa in the vertebral
fracture group, about half the loss could be attributed to
postmenopausal age and half to other factors.
Key Words: Activation-Analysis-Osteoporosis.
Introduction
In vivo neutron activation analysis (IVNAA) is an established
technique for measuring total body calcium (TBCa) and has
been described by five other groups (Chamberlain etal., 1968;
Cohn et al., 1976a; Palmer et al., 1968; Spinks et al., 1977;
Kennedy et al., 1979) as well as by ourselves (Kennedy et al.,
1982). Since 99% of TBCa is present in bone (Heany, 1963),
IVNAA can be used to measure bone mass and in this way
avoid the errors in sampling from different parts of the skele¬
ton. Two other groups have reported TBCa in women with
postmenopausal osteoporosis (Chesnut et al., 1977, Cohn
etal., 1974).
In this report we describe a formula for predicting TBCa
from the span and postmenopausal age based on a study of 20
normal women. This formula is then used to compare the bone
mass of women with vertebral or wrist fractures with their ex¬
pected bone mass. The degree of osteopenia associated with
these two types of fracture is also calculated.
Patients and Methods
Twenty women aged 46-66 years were selected from volunteers who
answered requests circulated in the hospital, in a factory, in the local
press, and on BBC Radio Scotland. The criteria for selection were
based on age (40-70 years) and the absence of a past history of back
pain, fragility fractures, artificial menopause, rheumatic, hepatic, renal,
or endocrine diseases, exposure to steroid or anticonvulsant therapy,
or excessive alcohol intake. Screening tests to exclude occult malab¬
sorption and disorders of calcium metabolism or of renal or hepatic
function were undertaken as follows: serum or plasma calcium,
phosphate, magnesium, alkaline phosphatase, albumin, parathyroid
hormone, 25-hydroxycalciferol, iron, iron-binding capacity, ferritin,
vitamin B12 and folic acid, urinary calcium, phosphate, magnesium,
hydroxyproline and creatinine clearance, and a full blood count.
Eight women with wrist fracture, aged 56-69 years, were selected
from a consecutive series of patients attending the orthopedic clinic.
Selection was made on the same basis as for the volunteers. Measure¬
ments of TBCa and of plasma and urine as for the normal women were
made 1 year after the fracture.
Fifteen women aged 48-71 years were referred to the endocrine
clinic for medical therapy of their vertebral osteoporosis. Back pain
had been present for less than 2 years in 11 of the 15 women. At least
two collapsed vertebrae were seen on a lateral radiograph of the
thoracolumbar spine in all patients. No selection was made of these
patients, and the same investigations as already described were per¬
formed together with isotope bone scans and bone biopsy when
indicated.
TBCa was measured by IVNAA using the MRC cyclotron in
Edinburgh (Williams et al., 1979) as the source of neutrons. The in¬
duced radiation was measured using four sodium iodine detectors
mounted in a whole-body counter. Computer analysis of the spectrum
and the value of a standard irradiated simultaneously with the subjects
gave the TBCa in 49Ca counts. The long-term precision, based on
anthropomorphic phantom measurements, was 1.8% (coefficient of
variation, CV) for a dose of 13 mSv (1.3 rem) (Kennedy et al., 1982). The
effect on measurement efficiency due to variation in body size was
determined experimentally. Calcium counts were converted to grams
of calcium using a correction formula from phantom measurements.
Biologic variation due to size and age was then reduced using multiple
regression analysis of height, arm span, weight, age and years
postmenopause, and lean body mass (% body fat was obtained using
skin calipers) (Durnin and Womersley, 1974). The factors relating most
closely to TBCa were found to be arm span and years postmenopause.
Informed consent was obtained from all patients. The study proto¬
col was approved by the Hospital Ethics Committee and by ARSAC
(Administration of Radioactive Substances Advisory Committee).
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Results
The TBCa in normal women was 820 ± 124 g (mean ± stan¬
dard deviation, SD). This gave a CV of 15.1% before any
allowance was made for span or postmenopausal age. The
greatest reduction in variancewas achieved using the following
formula to obtain the predicted TBCa (TBCap):
TBCap = as1 69e_0 015y (r = 0.90, P < 0.001)
where:
TBCap is in grams
ct= 399
s = arm span in meters
y = years postmenopause
The arm span not only related more closely to TBCa than height
but also eliminated the error due to loss of height associated
with vertebral fractures. The formula applied to peri-
menopausal women and to women up to 22 years post-
menopause. The regression is based on an exponential loss of
bone mass starting at the time of the menopause. The esti¬
mated rate of bone loss was 1.5% per year. The ratio
TBCa/TBCap has been defined by Cohn et al. as the calcium
ratio (Cafl) (Cohn et al., 1974) and for our normal women was
1.00 with a CV of 6.6%.
The TBCa in women with vertebral and wrist fractures was
649 ± 87 g and 787 ± 72 g, respectively (mean ± SD). The
values of span and postmenopausal age are shown in Table I
In the women with wrist fractures the CaR was 1.00 ± 0.10,
which was normal (Fig. 1) Six of the 15 women with vertebral
fracture had postmenopausal ages greater than 22 years. This
was the greatest postmenopausal age among the normal
women; the formula for TBCap cannot be extrapolated to
cover the women in this group who were more than 22 years
past the menopause. In the remaining 9 women the Cafi
was 0.87 ± 0.06, significantly lower than in normal women
(P < 0.01). Factors that may have contributed to this excessive
bone loss were identified in 5 of the 9 patients, namely,
prednisolone therapy for polymyalgia rheumatica, phenytoin
therapy for epilepsy, previous history of thyrotoxicosis, atrophic
gastritis, and moderate impairment of renal function (creatinine
clearance 20 ml/min).
When TBCa was normalized for span alone (TBCa/as169),
i.e., y = 0 in the equation for TBCap, an estimate of osteopenia
in the patients with fractures could be made by comparing the
values with the Cafl of the normal women (Fig. 2). The
TBCa/as1 69 for women with vertebral and wrist fractures
and for normal women were 0.69 ± 0.06, 0.84 ± 0.08, and
0.88 ± 0.11, respectively (mean ± SD). All the women with
vertebral fractures had values less than 0.78, but 3 of the 8
women with wrist fractures and 5 of the 20 normal women also
had values below 0.78.
Table I. Span and postmenopausal age in normal women and
women with vertebral and wrist fractures. The years
postmenopause in the vertebral fracture group were
significantly higher than in the normal women (P<0.002).
Group Number Span (m)Mean ± SD
Postmenopausal age (yr)
mean ± SD
Normal women 20 1.65 ± 0.07 8.9 ± 7.0
Vertebral fracture 15 1.66 ± 0.07 21.9 ± 8.4












Fig. 1. Calcium ratio (Ca„) in normal women (O), women with wrist
fracture (A), and women with vertebral fracture (□). Horizontal lines



















Fig. 2. Total body calcium normalized for span (TBCa/as ) in
normal women (O), women with wrist fracture (A), and women with
vertebral fracture (□). Horizontal lines are mean Ca„ ± 2 SD for
normal women.
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Discussion
TBCa for the normal women (820 ± 124 g) was similar to that
reported by Cohn et al. (1976b), namely, 804 ± 106 g for
normal women aged 50-59 years. The TBCa for women with
vertebral fractures (649 ± 87 g) resembled that described by
Chesnut et al. (1977) (mean 688 g ± 94 g) and Cohn et al.
(1974) (mean 590 g ± 108 g). However, some of the patients
in the latter two groups did not have vertebral compression
fractures but only demineralized vertebrae.
Different formulae for TBCap have been reported. Cohn et
al. (1976b) use age from birth, height, and total body potas¬
sium: the latter two also may be age dependent. Nelp et al.
(1972) predict TBCa from the cube of the patient's height. In
the present report it was noted that span was more effective
than height in reducing variance, and we would prefer to use
span, as it is unaffected by the height loss due to vertebral
compression fractures.
The CV of TBCap in normal women was 6.6% as compared
with 7.1% reported by Cohn et al. (1976b). The latter group
found that the rate of bone loss after the age of 55 years was
1.1% per year compared with the rate of 1.5% per year after
the menopause in our group.
The Cafl was 0.87 in the women with vertebral fractures,
similar to the value of 0.82 found by Cohnetal. (1974). An early
menopause in these two groups of women may explain in part
their osteopenia. Additional factors, including a low TBCa at
the time of the menopause or an accelerated loss of bone after
the menopause, must also have been present. The normal
Cafi in the women with wrist fractures suggests that they
were not specifically prone to fracture compared with other
postmenopausal women.
Expressions such as TBCa/as1 69 to describe the degree of
osteopenia have not been reported previously. Although the
sample size of 15 was small, in this group of women vertebral
crush fractures occurred when total body calcium was below
80% of that predicted from span alone, i.e., TBCa/as169 less
than 0.78. However there was some overlap of these values
with the other groups of women. It may be possible, therefore,
to predict those women likely to sustain a vertebral fracture and
to recommend treatment, estrogens, for example, aimed at
preventing further loss of bone mass.
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RESUME
Le calcium corporel total (Ca CT) a ete mesure par activation neutronique in vivo avec Taide d'un cyclotron chez20 femmes en bonne sante, 15 femmes
ayant un tassement vertebral et 8 femmes atteintes de fracture de Textremite inferieure du radius. La precision de la technique, evaluee sur des
fantomes, est de 1,8 pour cent pour une dose de 13 mSv. Une formule permettant de predire le CaCT a partir du delai ecoule depuis la menopause a ete
calculee pour les 20 femmes normales. Le coefficient de variation du CaCT apres normalisation est de 6,6 pour cent dans la population temoin. Les
valeurs moyennes du CaCT dans le groupe avec fracture vertebrale et dans celui avec fracture du radius etaient respectivement egales a 69 et 84 pour
cent du CaCT des femmes au moment de leur menopause. Le CaCT reduit dans le groupe avec fracture du radius peut etre attribue a la perte osseuse
post-menopausique. La reduction du CaCT dans le groupe avec tassements vertebraux peut etre imputee pour moitie environ a l etat post-
menopausique et pour moitie a d'autres facteurs.
